arginine vasopressin has been researched along with Cardiac Failure in 235 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 55 (23.40) | 18.7374 |
| 1990's | 51 (21.70) | 18.2507 |
| 2000's | 67 (28.51) | 29.6817 |
| 2010's | 57 (24.26) | 24.3611 |
| 2020's | 5 (2.13) | 2.80 |
| Authors | Studies |
|---|---|
| Doi, T; Fukahara, K; Imamura, T; Kinugawa, K; Yamashita, S; Yokoyama, S; Yoshimura, N | 1 |
| Szczepanska-Sadowska, E | 1 |
| Fujioka, H; Imamura, T; Kakeshita, K; Kinugawa, K; Koike, T; Yamazaki, H | 1 |
| Davila, CD; Udelson, JE | 1 |
| Ge, N; Huang, Y; Li, S; Li, T; Liu, C; Liu, K; Wang, Y; Zhu, X | 1 |
| Dewi, IP; Fagi, RA; Suwanto, D | 1 |
| Fujiu, K; Iwami, S; Komuro, I; Manabe, I; Matsumoto, S; Nagai, R; Nakae, S; Nakayama, Y; Noshita, K; Ogata, F; Shibata, M | 1 |
| Gustafsson, F; Vishram-Nielsen, JK | 1 |
| Atsumi, W; Hirayama, A; Tachibana, E; Tani, S | 1 |
| Akers, SR; Ansari, B; Chirinos, JA; Fedorova, OV; Hussain, A; Lakatta, EG; Lee, J; Mustafa, A; Oldland, G; Sardana, M; Wei, W | 1 |
| Felder, RB; Wei, SG; Weiss, RM; Yu, Y | 1 |
| Horibata, Y; Kawasoe, Y; Murakami, T; Niwa, K; Tateno, S | 1 |
| Bigelow, W; Harrell, C; Karki, KB; Krebs, J; Saini, A; Tadphale, SD; Tansey, J; Towbin, JA | 1 |
| Bao, LZ; Guo, ZF; Jing, Q; Qudirat, H; Shen, M; Shi, JB; Song, JW; Su, T; Wang, ZK; Zhao, XX; Zheng, X | 1 |
| Hori, M | 1 |
| Bulmer, BJ; Scollan, KF; Sisson, DD | 1 |
| Brønd, L; Christensen, S; Graebe, M; Hadrup, N; Jonassen, TE; Müllertz, KM; Nielsen, J; Nielsen, S; Torp, M | 1 |
| Iwanaga, Y; Niizuma, S | 1 |
| Goldsmith, SR; Kalra, A; Maharaj, V | 1 |
| Alvarez, R; Cheung, JY; Feldman, AM; Hamad, E; Tilley, DG; Tsai, EJ; Zhu, W | 1 |
| Iwao, H; Izumi, Y; Miura, K | 1 |
| Jiang, RY; Lai, WY; Lin, S; Ren, H; Shen, QB; Wu, ZL; Xu, DL; Ye, TC; Zeng, QC | 1 |
| Fujino, T; Hatano, M; Imamura, T; Inaba, T; Kinugawa, K; Komuro, I; Maki, H; Yao, A | 1 |
| Sato, N | 1 |
| Barr, LA; Carter, RL; Cheung, JY; Coleman, RC; Feldman, AM; Gao, E; Grisanti, LA; Houser, SR; Koch, WJ; Li, X; Makarewich, CA; Myers, VD; Song, J; Tilley, DG; Troupes, CD; Yu, D; Zhu, W | 1 |
| Balling, L; Gustafsson, F | 1 |
| Blais, J; Chiodo, J; Friend, K; Shoaf, S | 1 |
| Alvarez, R; Cheung, JY; Feldman, AM; Hamad, E; Tilley, DG; Tsai, E; Zhu, W | 1 |
| Grieten, L; Mullens, W; Nijst, P; Steels, P; Tang, WH; Verbrugge, FH | 1 |
| How, OJ; Kildal, AB; Myrmel, T; Sanden, E; Stenberg, TA | 1 |
| Chen, X; Gao, X; Li, Q; Lu, G; Tang, K | 1 |
| Małyszko, J; Łukaszyk, E | 1 |
| Imamura, T; Kinugawa, K | 2 |
| Akaike, M; Bando, M; Bando, S; Hara, T; Ise, T; Iwase, T; Kadota, M; Kawabata, Y; Matsuura, T; Ogasawara, K; Sata, M; Soeki, T; Ueno, R; Wakatsuki, T; Yagi, S; Yamada, H; Yamaguchi, K | 1 |
| Imamura, T; Kinugawa, K; Komuro, I; Nitta, D | 1 |
| Cantatrione, C; De Vecchis, R; Mazzei, D | 1 |
| Kikuchi, S; Kitada, S; Ohte, N; Sonoda, H; Yoshida, A | 1 |
| Chen, H; Maliszewska-Scislo, M; Rossi, NF | 1 |
| Finley, JJ; Konstam, MA; Udelson, JE | 1 |
| Schrier, RW | 2 |
| Funayama, H; Ishikawa, SE; Kasono, K; Saito, T | 1 |
| Chatterjee, K | 2 |
| Farmakis, D; Filippatos, G; Gheorghiade, M; Kremastinos, DT | 1 |
| Boerrigter, G; Burnett, JC; Costello-Boerrigter, LC | 2 |
| Kumar, SK; Mather, PJ | 1 |
| Goldsmith, SR | 9 |
| Amsterdam, E; Summers, RL | 1 |
| Anker, SD; Bergmann, A; Dickstein, K; Hartmann, O; Hillege, HL; Squire, I; Struck, J; van Veldhuisen, DJ; von Haehling, S; Voors, AA | 1 |
| Boyd, JH; Indrambarya, T; McConechy, M; Walley, KR; Wang, Y | 1 |
| Rosner, MH | 1 |
| Tai, MK | 1 |
| Gullo, A; Li Volti, G; Li, Y; Ristagno, G; Santonocito, C | 1 |
| Troughton, RW; Yandle, TG | 1 |
| Ghali, JK; Tam, SW | 1 |
| Morgenthaler, NG | 1 |
| Ronco, C; Rosner, MH | 1 |
| Komai, Y; Palaniyandi, SS; Sukumaran, V; Thandavarayan, RA; Veeraveedu, PT; Watanabe, K; Yamaguchi, K | 1 |
| Christ-Crain, M; Katan, M | 1 |
| Isnard, R | 1 |
| Daifallah, S; Farah, JO; Ghali, JK; Zmily, HD | 1 |
| Chiong, JR; Jao, GT | 1 |
| Cantillo, DS; Comín Colet, J; Robledo, GG | 1 |
| Fürstner, C; Gheorghiade, M; Kolkhof, P; Mondritzki, T; Sabbah, HN; Schaefer, S; Schmeck, C; Siedentop, H; Truebel, H | 1 |
| Ji, QL; Lin, QQ; Lin, R; Wang, WR; Yang, LN; Zhang, JY; Zhang, KF | 1 |
| Daifallah, S; Ghali, JK; Khan, NS; Zmily, HD | 1 |
| DeVita, MV; Michelis, MF; Vaghasiya, RP | 1 |
| Ako, J; Funayama, H; Ishikawa, SE; Momomura, S; Nakamura, T; Sugawara, Y; Tada, Y | 1 |
| Brønd, L; Christensen, S; Jonassen, TE; Nielsen, JB; Nielsen, S; Torp, M | 1 |
| Fukunami, M; Hori, M; Izumi, T; Matsuzaki, M | 1 |
| Fujiki, H; Nakamura, S; Nakayama, S; Onogawa, T; Sakamoto, Y; Yamamura, Y | 1 |
| Akahoshi, Y; Fujiki, H; Iwanaga, Y; Miyazaki, S; Morooka, H; Nakano, Y; Takase, T; Tamaki, Y | 1 |
| Ishikawa, SE | 1 |
| Ako, J; Arao, K; Fujiwara, T; Ishikawa, SE; Momomura, S; Sakakura, K; Suga, C; Sugawara, Y; Wada, H | 1 |
| Ambrosy, AP; Fought, AJ; Gheorghiade, M; Goldsmith, SR; Greene, SJ; Konstam, MA; Kwasny, MJ; Lanfear, DE; Maggioni, AP; Sabbah, HN; Swedberg, K; Yancy, CW; Zannad, F | 1 |
| Adams, KF; Barbagelata, A; Elkayam, U; Gattis, WA; Gheorghiade, M; O'Connor, CM; Orlandi, C | 1 |
| Bech, JN; Bentzen, H; Nyvad, O; Pedersen, EB; Pedersen, RS | 1 |
| Krum, H; Liew, D | 1 |
| Anand, IS; Chandrashekhar, Y; Gupta, S; Prahash, AJ; Roy, S; Sen, S | 1 |
| Czerwiec, F; Gheorghiade, M; Kambayashi, J; Niazi, I; Orlandi, C; Ouyang, J; Zampino, M | 1 |
| Adams, KF; Gattis, W; Gheorghiade, M; Lee, CR; O'connor, CM; Patterson, JH; Watkins, ML | 1 |
| BROH-KAHN, RH; HAAR, H; McGAVACK, TH; PEARSON, S | 1 |
| HEINTZ, R; SCHNEIDER, E | 1 |
| KURODA, R | 1 |
| FRANKEN, FH; IRMSCHER, K; SIADATPUR, A | 1 |
| Thibonnier, M | 1 |
| Bentzen, H; Nyvad, O; Pedersen, EB; Pedersen, RS | 1 |
| Appel, J; Hildebrandt, P; Kjaer, A; Petersen, CL | 1 |
| Francis, GS; Tang, WH | 1 |
| Clunie, S; Denfield, SW; Dreyer, WJ; McMahon, CJ; Price, JF; Radovancevic, B; Smith, EO; Towbin, JA | 1 |
| Abassi, ZA; Hoffman, A; Winaver, J | 1 |
| Funayama, H; Ishikawa, SE; Kawakami, M; Nakamura, T; Saito, M; Saito, T; Yoshimura, A | 1 |
| Sanghi, P; Schwarz, ER; Uretsky, BF | 1 |
| Fujii, M; Nakamura, T | 1 |
| Golestaneh, L; Le Jemtel, TH; Talreja, A | 1 |
| Funayama, H; Ishikawa, SE; Kawakami, M; Nakamura, T; Saito, M; Tsuruya, Y; Yoshimura, A | 1 |
| Sanghi, P; Schwarz, ER | 1 |
| De Luca, L; Fedele, F; Gheorghiade, M; Orlandi, C; Udelson, JE | 1 |
| Bech, JN; Jensen, P; Nyvad, O; Pedersen, EB; Starklint, J | 1 |
| Streefkerk, JO; van Zwieten, PA | 1 |
| Gheorghiade, M | 1 |
| McFarlane, S; Rai, A; Sowers, JR; Whaley-Connell, A | 1 |
| Omland, T; Solberg, OG | 1 |
| Arai, Y; Fujimori, A; Sasamata, M; Sudoh, K | 1 |
| LeJemtel, TH; Serrano, C | 1 |
| Chen, SY; Tang, WH | 1 |
| Ali, F; Ghali, JK; Guglin, M; Vaitkevicius, P | 1 |
| Dünser, MW; Hasibeder, WR; Jochberger, S; Luckner, G; Mayr, VD; Wenzel, V | 1 |
| Aizawa, Y; Kodama, M; Ma, M; Palaniyandi, SS; Suzuki, K; Veeraveedu, PT; Watanabe, K; Yamaguchi, K | 1 |
| Kumar, S; Mather, PJ; Rubin, S; Whellan, DJ | 1 |
| Głuszek, J; Olszewski, W | 1 |
| Charles, CJ; Nicholls, MG; Rademaker, MT; Richards, AM | 1 |
| Aizawa, Y; Kodama, M; Ma, M; Palaniyandi, SS; Veeraveedu, PT; Watanabe, K; Yamaguchi, K | 1 |
| Cotter, G; Dittrich, HC; Gheorghiade, M; Metra, M; Milo-Cotter, O | 1 |
| Dünser, MW; Jochberger, S; Morgenthaler, NG; Struck, J | 1 |
| Schweiger, TA; Zdanowicz, MM | 1 |
| Bichet, D; Schrier, RW | 1 |
| Cohn, JN; Francis, GS; Goldsmith, SR; Levine, TB; Olivari, MT | 1 |
| Holzschuh, M; Kochsiek, K; Liebau, G; Riegger, GA; Steilner, H; Witkowski, D | 1 |
| Cohn, JN; Cowley, AW; Francis, GS; Goldsmith, SR; Levine, TB | 2 |
| Cohn, JN; Francis, GS; Goldsmith, SR; Levine, TB; Olivari, MT; Pierpont, G | 1 |
| Harris, P | 1 |
| Bichet, DG; Schrier, RW | 1 |
| Arnold, PE; Berl, T; Bichet, D; Chaimovitz, C; Schrier, RW; Szatalowicz, VL | 1 |
| Arakawa, K; Ichihara, A; Matsumoto, A; Murakami, M; Naitoh, M; Nakamoto, H; Oka, K; Saruta, T; Suzuki, H; Yamamura, Y | 1 |
| Beermann, B; Berglund, H; Jensen-Urstad, M; Nyquist, O; Theodorsson, E | 2 |
| Elsner, D; Forssmann, WG; Kromer, EP; Muders, F; Müntze, A; Riegger, GA | 1 |
| Abraham, WT | 1 |
| Benedict, CR | 1 |
| Augelli, NV; Kerber, RE; Levett, JM; Lund, DD; Marinelli, CC; Nader, S; Pardini, BJ; Schmid, PG; Scott, BD | 1 |
| Chen, WH; Conway, RS; Natelson, BH; Ting, W | 1 |
| Bakris, GL; Riley, DJ; Weir, M | 1 |
| Cao, SP; Zhao, LY | 1 |
| Miura, Y; Nakano, H; Nakayama, M; Suzuki, S; Tsuchida, H; Yamada, K; Yoshida, S | 1 |
| Mimura, N; Miura, Y; Nakano, H; Nakayama, M; Yamada, K; Yoshida, S | 1 |
| Akaishi, M; Anzai, T; Baba, A; Handa, S; Mitamura, H; Nishimura, H; Ogawa, S; Yoshikawa, T | 1 |
| Cosín Aguilar, J; Cruz Fernández, JM; de Teresa Galván, E; Ferreira Montero, IJ; López-Sendón, J; Soler Soler, J; Tamargo Menéndez, J | 1 |
| Chang, Q; Conway, RS; Natelson, BH; Ottenweller, JE | 1 |
| Lerch, R; Montessuit, C | 1 |
| Kinnunen, P; Magga, J; Marttila, M; Romppanen, H; Ruskoaho, H; Szokodi, I; Vuolteenaho, O | 1 |
| Ishikawa, S; Saito, T | 2 |
| Martin, PY; Schrier, RW | 2 |
| Aldred, KL; Burrell, LM; Chan, RK; Johnston, CI; Phillips, PA; Risvanis, J | 1 |
| Ito, S; Kaizuma, S; Kanazawa, M; Kimura, T; Marumo, R; Matsubara, M; Nogae, S; Saito, T | 1 |
| Doughty, R; Espiner, EA; Frampton, C; Ikram, H; Macmahon, S; Nicholls, MG; Richards, AM; Sharpe, N; Yandle, TG | 1 |
| Serradeil-Le Gal, C | 1 |
| Albright, JD; Bailey, T; Cervoni, P; Chan, PS; Coupet, J; Dusza, JP; Hartupee, D; Lai, F; Lock, TY; Mazandarani, H; Ning, X; Ochalski, L; Park, HC; Ru, X; Shepherd, C; Spinelli, W; Tanikella, T; Taylor, JR | 1 |
| Lin, S; Ma, J; Peng, A | 1 |
| Abraham, WT; Schrier, RW | 1 |
| Abraham, WT; Lieming, X; Martin, PY; Ohara, M; Olson, BR; Oren, RM; Schrier, RW | 1 |
| Cannavale, V; Lombardi, G; Luciano, A; Macchia, V; Mariano, A; Mazzitelli, L; Rossi, R; Savastano, S; Tauchmanovà, L; Tommaselli, AP; Valentino, R | 1 |
| Cecioni, I; Costoli, A; Galanti, G; Modesti, PA; Poggesi, L; Serneri, GG | 1 |
| Martin, PY | 1 |
| Cohn, JN | 1 |
| Anderson, AS; Ward, RP | 1 |
| Hoffmann, E; Laugwitz, KL; Moretti, A; Pragst, I; Rosport, K; Schömig, A; Ueblacker, P; Ungerer, M; Weig, HJ | 1 |
| Abassi, ZA; Brodsky, S; Dobkin, I; Hoffman, A; Karram, T; Winaver, J | 1 |
| Brandão, F; Cerqueira-Gomes, M; da Faria, DB; Polónia, J; Ramalhão, C | 1 |
| Chanoine, F; Ghali, JK; Ghazzi, M; Hendrix, GH; Konstam, MA; Painchaud, CA; Pressler, ML; Selaru, P; Smith, WB; Thomas, I; Udelson, JE | 1 |
| Groenning, BA; Hildebrandt, PR; Kjaer, A; Larsson, HB; Nilsson, JC; Sondergaard, L | 1 |
| Balding, LC; Burrell, LM; Johnston, CI; Naitoh, M; Risvanis, J | 1 |
| Arakawa, N; Funakoshi, T; Hiramori, K; Nakamura, M; Yoshida, H | 1 |
| Kromer, EP; Riegger, GA | 1 |
| Parmley, WW | 2 |
| Hartter, E; Kargl, R; Zirm, A; Zirm, B | 1 |
| Chalmers, J; Lightman, SL; Noble, MI; Pate, P; Song, G; Sutton, R; Travill, CM; Williams, TD | 1 |
| Eide, IK; Eritsland, J; Kjeldsen, SE; Os, I; Thaulow, E; Westheim, A | 1 |
| Arnal, JF; Bourdarias, JP; Corvol, P; Cudek, P; Dussaule, JC; Guyenne, TT; Michel, JB; Plouin, PF; Rullière, R; Valty, J | 1 |
| Gross, P; Hensen, J; Ketteler, M; Rascher, W; Schömig, A | 1 |
| Arnold, J; Donovan, K; Hampton, D; Mulkerrin, E; Penney, MD; Sykes, D | 1 |
| Franco, R; Gavras, H; Gavras, I; Wang, YX | 1 |
| Gavras, H | 2 |
| Arnolda, L; Johnston, CI; McGrath, BP | 1 |
| Edvinsson, L; Ekman, R; Hedner, P; Sjöholm, A; Valdemarsson, S | 1 |
| Betschart, AR; Kolesar, JA; Murali, S; Reddy, PS; Uretsky, BF; Verbalis, JG | 1 |
| Benedict, C; Francis, GS; Johnstone, DE; Kirlin, PC; Kubo, SH; Liang, CS; Nicklas, J; Rudin-Toretsky, E; Yusuf, S | 1 |
| Gay, RG; Goldman, S; Raya, TE | 1 |
| Imai, N; Liang, CS; Sladek, CD; Stone, CK | 1 |
| Franco, R; Gavras, H; Gavras, I; Mulinari, RA; Wang, YX | 1 |
| Bichet, DG; Kortas, C; Rouleau, JL; Schrier, RW | 1 |
| Brunner, HR; Hofbauer, KG; Nicod, P; Nussberger, J; Waeber, B | 1 |
| Cannon, PJ | 1 |
| Favre, H; Gross, P; Hausmann, C; Ketteler, M; Lang, R; Rascher, W; Ritz, E | 1 |
| Ambrosioni, E; Borghi, C; Boschi, S; Capelli, M; Costa, FV; Magelli, C; Magnani, B; Varani, E | 1 |
| Broqvist, M; Dahlström, U; Karlberg, BE; Karlsson, E; Marklund, T | 1 |
| Brandão, F; Cerqueira-Gomes, M; de Faria, DB; Polónia, J; Ramalhão, C | 1 |
| Cody, RJ | 1 |
| Francis, GS | 1 |
| Cohn, JN; Francis, GS; Goldsmith, SR; Levine, TB; Olivari, MT; Siegel, RM | 1 |
| Riegger, AJ | 2 |
| Dansby, C; Kirlin, PC; Laird, C; Willis, PW | 1 |
| Francis, GS; Rector, TS; Wilson, BC | 1 |
| Generalovich, T; Reddy, PS; Uretsky, BF; Valdes, AM; Verbalis, JG | 2 |
| Dyckner, T; Wester, PO | 1 |
| Charlier, P; Cohen-Solal, A; Dahan, M; Gourgon, R; Jaeger, P; Juliard, JM | 1 |
| Bruckner, U; Silberbauer, K; Stanek, B | 1 |
| Gross, P; Hackenthal, E; Hausmann, C; Ketteler, M; Rascher, W; Reinhard, C; Ritz, E; Schömig, A | 1 |
| Danielsen, H; Jensen, T; Madsen, M; Pedersen, EB; Sørensen, SS; Thomsen, OO | 1 |
| Generalovich, T; Reddy, PS; Uretsky, BF; Valdes, A; Verbalis, JG | 1 |
| Hood, WB; Imai, N; Liang, CS; Sakamoto, S; Sladek, CD; Stone, CK | 1 |
| Kolesar, JA; Lawless, CE; Reddy, PS; Uretsky, BF; Valdes, AM; Verbalis, JG | 1 |
| Dweck, HS; Gewitz, MH; Stewart, JM; Woolf, PK; Zeballos, GA | 1 |
| Creager, MA; Cutler, SS; Faxon, DP; Gavras, H; Kohlmann, O; Ryan, TJ | 1 |
| Kochsiek, K; Riegger, GA | 1 |
| Bichet, DG; Kortas, C; Manzini, C; Marc-Aurèle, J; Mettauer, B; Rouleau, JL; Schrier, RW | 1 |
| Fournier, JF; Hannedouche, T | 1 |
| Crozier, IG; Hofbauer, KG; Ikram, H; Nicholls, MG | 1 |
| Cowley, AW; Francis, GS; Goldsmith, SR | 1 |
| Cohn, JN; Cowley, AW; Francis, GS; Goldenberg, IF; Goldsmith, SR | 1 |
| Biollaz, J; Goy, JJ; Hofbauer, KG; Nicod, P; Nussberger, J; Polikar, R; Schaller, MD; Schlapfer, J; Turini, GA; Waeber, B | 1 |
| Brunner, HR; Bussien, JP; Goy, J; Hofbauer, KG; Nicod, P; Nussberger, J; Turini, GA; Waeber, B | 1 |
| Brunner, HR; Bussien, JP; Goy, JJ; Hofbauer, KG; Nicod, P; Nussberger, J; Turini, G; Waeber, B | 1 |
| du Souich, P; Gutkowska, J; Lambert, C; Larose, P; Ong, H | 1 |
| Dodge, D; Goldsmith, SR | 1 |
82 review(s) available for arginine vasopressin and Cardiac Failure
| Article | Year |
|---|---|
The Heart as a Target of Vasopressin and Other Cardiovascular Peptides in Health and Cardiovascular Diseases.
Topics: Angiotensins; Arginine Vasopressin; Cardiovascular Diseases; Cardiovascular System; Cytokines; Heart Failure; Humans; Hypertension; Lung; Oxytocin; Vasopressins | 2022 |
Hypervolemic Hyponatremia in Heart Failure.
Topics: Arginine Vasopressin; Heart Failure; Humans; Hyponatremia | 2019 |
Hyponatremia in heart failure: not just 135 to 145.
Topics: Arginine Vasopressin; Electrolytes; Heart Failure; Humans; Hyponatremia; Renin-Angiotensin System | 2021 |
Vasopressin and Vasopressin Antagonists in Heart Failure.
Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Glycopeptides; Heart Failure; Hemodynamics; Humans; Hyponatremia; Receptors, Vasopressin; Tolvaptan; Vasopressins | 2017 |
Vasopressin receptor antagonists: from pivotal trials to current practice.
Topics: Antidiuretic Agents; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Heart Failure; Hormone Antagonists; Humans; Tolvaptan | 2014 |
Therapeutic potential of vasopressin-receptor antagonists in heart failure.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzamides; Benzazepines; Body Water; Clinical Trials as Topic; Disease Models, Animal; Heart Failure; Homeostasis; Humans; Hyponatremia; Morpholines; Pyrroles; Receptors, Vasopressin; Spiro Compounds; Tolvaptan; Ventricular Remodeling | 2014 |
Copeptin as a biomarker in heart failure.
Topics: Arginine Vasopressin; Biomarkers; Glycopeptides; Heart Failure; Humans; Myocardial Infarction; Natriuretic Peptide, Brain; Peptide Fragments; Precision Medicine; Severity of Illness Index | 2014 |
Hyponatremia in acute decompensated heart failure: depletion versus dilution.
Topics: Acute Disease; Animals; Arginine Vasopressin; Diuretics; Heart Failure; Humans; Hyponatremia; Mineralocorticoid Receptor Antagonists; Sodium Potassium Chloride Symporter Inhibitors | 2015 |
Copeptin: Pathophysiology and potential clinical impact.
Topics: Animals; Arginine Vasopressin; Biomarkers; Glycopeptides; Heart Failure; Humans; Renal Insufficiency, Chronic | 2015 |
Vasopressin receptor antagonists in patients with chronic heart failure.
Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Chronic Disease; Extracellular Fluid; Heart Failure; Humans; Hyponatremia; Sodium; Water-Electrolyte Balance | 2017 |
Arginine vasopressin antagonists for the treatment of heart failure and hyponatremia.
Topics: Arginine Vasopressin; Heart Failure; Humans; Hyponatremia; Receptors, Vasopressin; Vasopressins | 2008 |
Vasopressin and vasopressin antagonists in heart failure and hyponatremia.
Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Azepines; Benzamides; Benzazepines; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Heart Failure; Humans; Hyponatremia; Infusions, Intravenous; Male; Prognosis; Pyrroles; Randomized Controlled Trials as Topic; Receptors, Vasopressin; Risk Assessment; Survival Rate; Tolvaptan; Water-Electrolyte Imbalance | 2008 |
Pharmacology of vasopressin antagonists.
Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Azepines; Benzamides; Benzazepines; Benzodiazepines; Heart Failure; Humans; Morpholines; Pyrroles; Receptors, Vasopressin; Spiro Compounds; Tolvaptan | 2009 |
AVP receptor antagonists in patients with CHF.
Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Azepines; Benzamides; Benzazepines; Heart Failure; Humans; Hyponatremia; Pyrroles; Receptors, Vasopressin; Sodium | 2009 |
Treatment options for hyponatremia in heart failure.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Azepines; Benzamides; Benzazepines; Heart Failure; Humans; Hyponatremia; Inappropriate ADH Syndrome; Pyrroles; Sodium Potassium Chloride Symporter Inhibitors; Tolvaptan; Treatment Outcome | 2009 |
Pathophysiology of acute decompensated heart failure.
Topics: Arginine Vasopressin; Cardiac Output; Cytokines; Dehydration; Heart Failure; Heart Failure, Diastolic; Hemodynamics; Homeostasis; Humans; Models, Cardiovascular; Myocardial Contraction; Natriuretic Peptides; Pulmonary Edema; Renin-Angiotensin System; Sympathetic Nervous System; Venous Pressure | 2009 |
Hyponatremia in heart failure: the role of arginine vasopressin and diuretics.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Clinical Trials as Topic; Diuretics; Heart Failure; Humans; Hyponatremia; Quality of Life | 2009 |
[Evidence-based practice of fluid restriction in patients with heart failure].
Topics: Arginine Vasopressin; Diuretics; Drinking; Evidence-Based Medicine; Heart Failure; Humans; Renin-Angiotensin System; Sodium, Dietary | 2009 |
Biomarkers of myocardial injury after cardiac arrest or myocardial ischemia.
Topics: Adrenomedullin; Arginine Vasopressin; Biomarkers; C-Reactive Protein; Cardiopulmonary Resuscitation; Creatine Kinase; Endothelin-1; Heart Arrest; Heart Failure; Humans; Immunity, Innate; Myocardial Ischemia; Natriuretic Peptides; Serum Amyloid P-Component; Troponin | 2010 |
The critical link of hypervolemia and hyponatremia in heart failure and the potential role of arginine vasopressin antagonists.
Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzamides; Benzazepines; Blood Pressure; Blood Volume; Female; Heart Failure; Humans; Hypertension; Hyponatremia; Male; Prevalence; Prognosis; Pyrroles; Receptors, Vasopressin; Tolvaptan; United States; Water-Electrolyte Balance | 2010 |
Copeptin: a biomarker of cardiovascular and renal function.
Topics: Arginine Vasopressin; Biomarkers; Blood Volume; Cardiovascular Diseases; Cardiovascular System; Glycopeptides; Heart Failure; Humans; Kidney; Kidney Diseases; Myocardial Infarction; Prognosis; ROC Curve; Shock, Cardiogenic; Stroke; Vasopressins | 2010 |
Hyponatremia in heart failure: the role of arginine vasopressin and its antagonism.
Topics: Antidiuretic Agents; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Blood Volume; Diuretics; Heart Failure; Humans; Hyponatremia; Risk Factors | 2010 |
Arginine vasopressin receptor antagonists (vaptans): pharmacological tools and potential therapeutic agents.
Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Clinical Trials as Topic; Drug Evaluation, Preclinical; Heart Failure; Humans; Hyponatremia; Receptors, Vasopressin; Sodium Potassium Chloride Symporter Inhibitors; Tolvaptan | 2010 |
The stress hormone copeptin: a new prognostic biomarker in acute illness.
Topics: Acute Disease; Adrenocorticotropic Hormone; Arginine Vasopressin; Biomarkers; C-Reactive Protein; Cerebral Infarction; Corticotropin-Releasing Hormone; Glycopeptides; Heart Failure; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Myocardial Infarction; Pituitary-Adrenal System; Pneumonia, Bacterial; Prognosis; Pulmonary Disease, Chronic Obstructive; Sepsis; Shock, Septic; Survival Analysis | 2010 |
Lixivaptan, a non-peptide vasopressin V2 receptor antagonist for the potential oral treatment of hyponatremia.
Topics: Administration, Oral; Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzamides; Clinical Trials as Topic; Dogs; Heart Failure; Humans; Hyponatremia; Pyrroles; Rats | 2010 |
Hyponatremia in acute decompensated heart failure: mechanisms, prognosis, and treatment options.
Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Biomarkers; Fluid Therapy; Heart Failure; Hormone Antagonists; Humans; Hyponatremia; Receptors, Vasopressin; Renin-Angiotensin System; Sodium; Tolvaptan; Treatment Outcome; Ventricular Dysfunction | 2010 |
[Hyponatremia in heart failure: physiopathology and pharmacological approach].
Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzamides; Benzazepines; Body Water; Brain Edema; Demyelinating Diseases; Diuresis; Diuretics; Double-Blind Method; Heart Failure; Humans; Hyponatremia; Kidney; Multicenter Studies as Topic; Natriuresis; Pyrroles; Randomized Controlled Trials as Topic; Receptors, Vasopressin; Renin-Angiotensin System; Saline Solution, Hypertonic; Sympathetic Nervous System; Tolvaptan | 2010 |
The potential role for lixivaptan in heart failure and in hyponatremia.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzamides; Heart Failure; Humans; Hyponatremia; Plasma Volume; Pyrroles | 2011 |
[Endocrine disease: progress in diagnosis and treatment. Topics: II. Progress in treatment; 3. Pathological roles of vasopressin in water metabolism: vasopressin agonist and antagonists].
Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Diabetes Insipidus; Heart Failure; Humans; Hyponatremia; Inappropriate ADH Syndrome | 2012 |
New developments in the pharmacological treatment of chronic heart failure.
Topics: Arginine Vasopressin; Cardiovascular Agents; Clinical Trials as Topic; Endothelin Receptor Antagonists; Erythropoietin; Glycation End Products, Advanced; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunosuppressive Agents; Matrix Metalloproteinase Inhibitors; Mineralocorticoid Receptor Antagonists | 2003 |
Vasopressin: a new target for the treatment of heart failure.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Body Fluids; Cardiac Output, Low; Cardiomegaly; Heart Failure; Hemodynamics; Humans; Muscle Tonus; Muscle, Smooth, Vascular; Myocardial Contraction; Neurotransmitter Agents; Rats; Receptors, Vasopressin | 2003 |
Vasopressin receptor antagonists in heart failure.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Azepines; Benzamides; Benzazepines; Heart Failure; Humans; Pyrroles; Randomized Controlled Trials as Topic; Tolvaptan | 2003 |
Large A-V fistula: pathophysiological consequences and therapeutic perspectives.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine Vasopressin; Arteriovenous Fistula; Atrial Natriuretic Factor; Endothelins; Heart Failure; Humans; Nitric Oxide; Renin-Angiotensin System; Sympathetic Nervous System | 2003 |
Vasopressin antagonism: a future treatment option in heart failure.
Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Heart Failure; Humans; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Tolvaptan | 2005 |
[Chronic heart failure].
Topics: Arginine Vasopressin; Heart Failure; Humans | 2005 |
Neurohormonal activation in congestive heart failure and the role of vasopressin.
Topics: Angiotensin II Type 1 Receptor Blockers; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Heart Failure; Homeostasis; Humans; Renin-Angiotensin System; Sympathetic Nervous System | 2005 |
Vasopressin antagonists in heart failure.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Diuretics; Heart Failure; Humans; Randomized Controlled Trials as Topic; Tolvaptan; Water-Electrolyte Balance | 2004 |
Conivaptan: a selective vasopressin antagonist for the treatment of heart failure.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Clinical Trials as Topic; Heart Failure; Humans; Receptors, Vasopressin | 2006 |
Overview of vasopressin receptor antagonists in heart failure resulting in hospitalization.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Clinical Trials as Topic; Diuretics; Heart Failure; Humans; Patient Admission; Receptors, Vasopressin; Sodium | 2005 |
Vasopressin receptor antagonists: pharmacological tools and potential therapeutic agents.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Drug Design; Heart Failure; Hormone Antagonists; Humans; Hypertension; Inappropriate ADH Syndrome; Indoles; Presynaptic Terminals; Pyrrolidines; Receptors, Vasopressin; Renal Artery; Sympathetic Nervous System; Synaptic Transmission; Tolvaptan; Vasoconstriction; Vasoconstrictor Agents | 2006 |
Vasopressin receptor antagonists: mechanisms of action and potential effects in heart failure.
Topics: Antidiuretic Hormone Receptor Antagonists; Aquaporin 2; Arginine Vasopressin; Disease Progression; Heart Failure; Humans; Hyponatremia; Treatment Outcome; Vasopressins | 2006 |
The role of vasopressin in congestive heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antidiuretic Agents; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Heart Failure; Humans; Hyponatremia; Neurotransmitter Agents; Prognosis; Renin-Angiotensin System | 2006 |
Hyponatremia, arginine vasopressin dysregulation, and vasopressin receptor antagonism.
Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Blood Pressure; Heart Failure; Humans; Hyponatremia; Liver Cirrhosis; Water-Electrolyte Balance | 2006 |
[Arginine vasopressin antagonism--new treatment option in chronic heart failure].
Topics: Animals; Antidiuretic Agents; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Azepines; Benzamides; Benzazepines; Heart Failure; Humans; Nephrons; Prognosis; Pyrroles; Receptors, Vasopressin; Tolvaptan; Treatment Outcome; Vasoconstrictor Agents | 2007 |
Vasopressin receptor antagonists: potential indications and clinical results.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Drug Design; Drugs, Investigational; Heart Failure; Humans; Hyponatremia; Polycystic Kidney Diseases; Sodium | 2007 |
Vasopressin dysregulation: hyponatremia, fluid retention and congestive heart failure.
Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Heart Failure; Humans; Hyponatremia; Receptors, Vasopressin; Water Intoxication | 2007 |
Emerging drugs for acute and chronic heart failure: current and future developments.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Cardiotonic Agents; Clinical Trials as Topic; Genetic Therapy; Heart Failure; Hormone Replacement Therapy; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Matrix Metalloproteinase Inhibitors; Natriuretic Peptides; Purinergic P1 Receptor Antagonists; Renin | 2007 |
Therapeutic potential of vasopressin receptor antagonists.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Azepines; Benzamides; Benzazepines; Heart Failure; Humans; Hyponatremia; Inappropriate ADH Syndrome; Liver Cirrhosis; Morpholines; Pyrroles; Receptors, Vasopressin; Spiro Compounds; Tolvaptan | 2007 |
Treating hyponatremia in heart failure.
Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Diuretics; Furosemide; Heart Failure; Humans; Hyponatremia; Sodium Potassium Chloride Symporter Inhibitors | 2006 |
Hyponatremia and vasopressin antagonism in congestive heart failure.
Topics: Arginine Vasopressin; Azepines; Benzamides; Benzazepines; Chronic Disease; Clinical Trials as Topic; Diuretics; Heart Failure; Humans; Hyponatremia; Models, Biological; Pyrroles; Registries; Renin-Angiotensin System; Sodium; Tolvaptan; Treatment Outcome; Vasopressins | 2007 |
V2 receptor antagonism with tolvaptan in heart failure.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Clinical Trials as Topic; Diuretics; Heart Failure; Humans; Tolvaptan | 2007 |
[Vasopressin antagonists in treatment of hyponatremia].
Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Heart Failure; Hormone Antagonists; Humans; Hyponatremia; Inappropriate ADH Syndrome; Liver Cirrhosis; Sodium Chloride; Tolvaptan; Water-Electrolyte Balance | 2007 |
Fluid overload in acute heart failure--re-distribution and other mechanisms beyond fluid accumulation.
Topics: Arginine Vasopressin; Arteries; Disease Progression; Edema, Cardiac; Elasticity; Heart Failure; Humans; Kidney Failure, Chronic; Lung; Pulmonary Edema; Renin-Angiotensin System; Vascular Resistance; Vasodilator Agents; Water-Electrolyte Imbalance | 2008 |
Vasopressin-receptor antagonists in heart failure.
Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Azepines; Benzamides; Benzazepines; Cardiovascular Agents; Chronic Disease; Heart Failure; Humans; Hyponatremia; Pyrroles; Receptors, Vasopressin; Tolvaptan | 2008 |
The neurohumoral axis in congestive heart failure.
Topics: Animals; Arginine Vasopressin; Autonomic Nervous System Diseases; Heart Failure; Humans; Neurotransmitter Agents; Norepinephrine; Renin; Renin-Angiotensin System; Sympathetic Nervous System | 1984 |
Biology of cardiac failure.
Topics: Aldosterone; Arginine Vasopressin; Blood Circulation; Cardiac Output; Heart Failure; Humans; Kidney; Lung; Oxygen; Physical Exertion; Renin-Angiotensin System; Water-Electrolyte Imbalance | 1982 |
Osmotic and nonosmotic control of vasopressin release and the pathogenesis of impaired water excretion in adrenal, thyroid, and edematous disorders.
Topics: Adrenal Gland Diseases; Adrenal Insufficiency; Arginine Vasopressin; Blood Vessels; Edema; Heart Failure; Humans; Hypothyroidism; Liver Cirrhosis; Neurosecretory Systems; Osmolar Concentration; Thyroid Diseases; Water-Electrolyte Imbalance | 1981 |
New neurohormonal antagonists and atrial natriuretic peptide in the treatment of congestive heart failure.
Topics: Angiotensin II; Arginine Vasopressin; Atrial Natriuretic Factor; Heart Failure; Humans; Neurotransmitter Agents; Renin; Renin-Angiotensin System | 1994 |
Neurohumoral aspects of heart failure.
Topics: Animals; Arginine Vasopressin; Endothelins; Heart Failure; Hormones; Humans; Neurotransmitter Agents; Prognosis; Renin-Angiotensin System | 1994 |
Renal adaptation to the failing heart. Understanding the cascade of responses.
Topics: Adaptation, Physiological; Aldosterone; Angiotensin II; Arginine Vasopressin; Atrial Natriuretic Factor; Blood Volume; Endothelins; Heart Failure; Hemodynamics; Homeostasis; Humans; Kidney Diseases; Norepinephrine; Prostaglandins; Renal Circulation; Renin-Angiotensin System; Systole | 1994 |
[Neurohormonal factors in heart failure. II].
Topics: Arginine Vasopressin; Cardiotonic Agents; Death, Sudden, Cardiac; Diuretics; Endothelins; Follow-Up Studies; Heart Failure; Hemodynamics; Humans; Myocardial Infarction; Prognosis; Prostaglandins; Renin-Angiotensin System; Sympathetic Nervous System; Time Factors; Vasodilator Agents; Ventricular Dysfunction, Left | 1996 |
[Hypertrophy due to left cardiac insufficiency: role of the neurohumoral system].
Topics: Aldosterone; Angiotensin II; Arginine Vasopressin; Atrial Natriuretic Factor; Heart Failure; Humans; Hypertrophy, Left Ventricular; Neurotransmitter Agents; Norepinephrine; Renin; Stroke Volume; Systole; Ventricular Dysfunction, Left | 1997 |
[Disorders of body water regulation and the therapy--vasopressin antagonists].
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Clinical Trials as Topic; Heart Failure; Hormone Antagonists; Humans; Hyponatremia; Inappropriate ADH Syndrome; Indoles; Liver Cirrhosis, Experimental; Pyrrolidines | 1997 |
Role of aquaporin-2 water channels in urinary concentration and dilution defects.
Topics: Animals; Aquaporin 2; Aquaporin 6; Aquaporins; Arginine Vasopressin; Diabetes Insipidus, Nephrogenic; Heart Failure; Humans; Ion Channels; Kidney Concentrating Ability; RNA, Messenger | 1998 |
Recent advances in the understanding of water metabolism in heart failure.
Topics: Animals; Aquaporin 2; Aquaporin 6; Aquaporins; Arginine Vasopressin; Heart Failure; Humans; Hyponatremia; Kidney; Neuropeptides; Pressoreceptors; Receptors, Vasopressin; Sympathetic Nervous System; Water; Water-Electrolyte Balance | 1998 |
Nonpeptide antagonists for vasopressin receptors. Pharmacology of SR 121463A, a new potent and highly selective V2 receptor antagonist.
Topics: Adenylyl Cyclases; Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Deamino Arginine Vasopressin; Dogs; Heart Failure; Humans; Kidney; Morpholines; Rats; Rats, Inbred BB; Receptors, Vasopressin; Spiro Compounds; Water-Electrolyte Imbalance | 1998 |
VPA-985, a nonpeptide orally active and selective vasopressin V2 receptor antagonist.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Azepines; Benzamides; Blood Pressure; Cyclic AMP; Dogs; Heart Failure; Humans; Hyponatremia; Inappropriate ADH Syndrome; Kidney; Pyrroles; Receptors, Vasopressin | 1998 |
Hormones and hemodynamics in heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Arginine Vasopressin; Atrial Natriuretic Factor; Endothelins; Heart Failure; Hemodynamics; Humans; Natriuretic Peptide, Brain; Prostaglandins; Renin-Angiotensin System; Sympathetic Nervous System; Water-Electrolyte Balance | 1999 |
Recent advances in the understanding of water metabolism in heart failure (involvement of aquaporin).
Topics: Animals; Aquaporins; Arginine Vasopressin; Heart Failure; Humans; Water | 2000 |
Left ventricle and arteries: structure, function, hormones, and disease.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Arginine Vasopressin; Drug Combinations; Epinephrine; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Nitroprusside; Prazosin; Randomized Controlled Trials as Topic; Renin; Renin-Angiotensin System; Stroke Volume; Survival Analysis; Time Factors; Vasodilator Agents; Ventricular Dysfunction, Left; Ventricular Remodeling | 2001 |
Slowing the progression of CHF. Drug therapy to correct neurohormonal abnormalities.
Topics: Adrenergic beta-Antagonists; Age Distribution; Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Arginine Vasopressin; Atrial Natriuretic Factor; Disease Progression; Family Practice; Heart Failure; Hemodynamics; Humans; Mineralocorticoid Receptor Antagonists; Primary Health Care; Renin-Angiotensin System; United States; Ventricular Dysfunction, Left | 2001 |
[Neuro-hormonal mechanisms in heart failure -- from physiopathology to treatment].
Topics: Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Arginine Vasopressin; Atrial Natriuretic Factor; Heart Failure; Humans; Hyponatremia; Prognosis; Prostaglandins; Receptors, Dopamine; Renin-Angiotensin System; Sympathetic Nervous System; Vasodilation | 2001 |
Pathophysiology of congestive heart failure.
Topics: Aged; Arginine Vasopressin; Arrhythmias, Cardiac; Atrial Natriuretic Factor; Catecholamines; Coronary Disease; Heart Failure; Hemodynamics; Humans; Incidence; Myocardial Contraction; Renin-Angiotensin System; United States | 1992 |
[Recent advances in the investigation of the renin-angiotensin and cardiac natriuretic systems in patients with chronic heart insufficiency].
Topics: Adult; Aged; Aged, 80 and over; Angiotensinogen; Arginine Vasopressin; Atrial Natriuretic Factor; Cyclic GMP; Female; Heart Failure; Humans; Male; Middle Aged; Renin; Renin-Angiotensin System; Retinol-Binding Proteins; Retinol-Binding Proteins, Plasma; Sodium | 1991 |
Role of vasopressin in clinical hypertension and congestive cardiac failure: interaction with the sympathetic nervous system.
Topics: Animals; Arginine Vasopressin; Clinical Trials as Topic; Heart Failure; Humans; Hypertension; Sympathetic Nervous System; Vasopressins | 1991 |
Sodium retention in heart failure.
Topics: Arginine Vasopressin; Atrial Natriuretic Factor; Edema; Heart Failure; Humans; Kidney; Renin-Angiotensin System; Sodium | 1989 |
[Neuro-hormonal mechanisms in heart insufficiency--from physiopathology to treatment].
Topics: Angiotensin-Converting Enzyme Inhibitors; Arginine Vasopressin; Arrhythmias, Cardiac; Atrial Natriuretic Factor; Heart Failure; Humans; Hyponatremia; Kidney; Neurotransmitter Agents; Prognosis; Prostaglandins; Receptors, Dopamine; Renin-Angiotensin System; Sympathetic Nervous System | 1989 |
Pathophysiology and current therapy of congestive heart failure.
Topics: Anti-Arrhythmia Agents; Arginine Vasopressin; Cardiotonic Agents; Diuretics; Heart Failure; Humans; Myocardial Contraction; Renin-Angiotensin System; Sympathetic Nervous System; Vasodilator Agents | 1989 |
Neurohumoral mechanisms involved in congestive heart failure.
Topics: Angiotensin II; Animals; Arginine Vasopressin; Blood Vessels; Epinephrine; Heart Failure; Humans; Neurotransmitter Agents; Norepinephrine; Receptors, Neurotransmitter; Renin; Renin-Angiotensin System; Sympathetic Nervous System | 1985 |
Pathogenesis of sodium and water retention in high-output and low-output cardiac failure, nephrotic syndrome, cirrhosis, and pregnancy (1)
Topics: Arginine Vasopressin; Body Water; Cardiac Output; Cardiac Output, Low; Edema; Female; Heart Failure; Humans; Liver Cirrhosis; Male; Nephrotic Syndrome; Pregnancy; Pregnancy Complications; Sodium | 1988 |
Vasopressin as vasopressor.
Topics: Animals; Arginine Vasopressin; Blood Pressure; Heart Failure; Humans; Hypertension; Vasoconstrictor Agents | 1987 |
[Neurohormonal factors in congestive heart failure].
Topics: Arginine Vasopressin; Blood Circulation; Heart Failure; Humans; Neurosecretory Systems; Renin-Angiotensin System; Sympathetic Nervous System | 1987 |
19 trial(s) available for arginine vasopressin and Cardiac Failure
| Article | Year |
|---|---|
Increased urine aquaporin-2 relative to plasma arginine vasopressin is a novel marker of response to tolvaptan in patients with decompensated heart failure.
Topics: Adult; Aged; Antidiuretic Hormone Receptor Antagonists; Aquaporin 2; Arginine Vasopressin; Benzazepines; Biomarkers; Disease-Free Survival; Female; Heart Failure; Humans; Male; Middle Aged; Survival Rate; Tolvaptan | 2014 |
C-terminal provasopressin (copeptin) is a strong prognostic marker in patients with heart failure after an acute myocardial infarction: results from the OPTIMAAL study.
Topics: Aged; Arginine Vasopressin; Biomarkers; Enzyme-Linked Immunosorbent Assay; Female; Glycopeptides; Heart Failure; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Natriuretic Peptide, Brain; Peptide Fragments; Prognosis; Sensitivity and Specificity; Stroke Volume; Time Factors | 2009 |
Early development of hyponatremia implicates short- and long-term outcomes in ST-elevation acute myocardial infarction.
Topics: Aged; Aged, 80 and over; Arginine Vasopressin; Female; Heart Failure; Humans; Hyponatremia; Incidence; Male; Middle Aged; Myocardial Infarction; Sodium; Survival Rate; Time Factors | 2011 |
Efficacy and safety of tolvaptan in heart failure patients with volume overload despite the standard treatment with conventional diuretics: a phase III, randomized, double-blind, placebo-controlled study (QUEST study).
Topics: Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Body Weight; Diuretics; Double-Blind Method; Edema, Cardiac; Female; Heart Failure; Humans; Male; Middle Aged; Potassium; Sodium; Tolvaptan | 2011 |
Hyponatremia as a predictor for worsening heart failure in patients receiving cardiac resynchronization therapy.
Topics: Aged; Arginine Vasopressin; Cardiac Resynchronization Therapy; Female; Follow-Up Studies; Heart Failure; Humans; Hyponatremia; Male; Middle Aged; Predictive Value of Tests; Risk Factors; Sodium | 2013 |
Association of arginine vasopressin levels with outcomes and the effect of V2 blockade in patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST trial.
Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Cause of Death; Female; Follow-Up Studies; Heart Failure; Humans; Inpatients; Kaplan-Meier Estimate; Male; Middle Aged; Prognosis; Stroke Volume; Survival Rate; Tolvaptan; United States | 2013 |
Rationale and study design for a multicenter, randomized, double-blind, placebo-controlled study of the effects of tolvaptan on the acute and chronic outcomes of patients hospitalized with worsening congestive heart failure.
Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Disease Progression; Double-Blind Method; Heart Failure; Hospitalization; Humans; Patient Selection; Prospective Studies; Receptors, Vasopressin; Research Design; Tolvaptan | 2003 |
Vasopressin V2-receptor blockade with tolvaptan in patients with chronic heart failure: results from a double-blind, randomized trial.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Body Weight; Chronic Disease; Diuretics; Double-Blind Method; Edema, Cardiac; Female; Furosemide; Heart Failure; Humans; Hyponatremia; Male; Middle Aged; Osmolar Concentration; Sodium; Tolvaptan; Treatment Outcome; Urinalysis; Water-Electrolyte Balance | 2003 |
Increased urinary aquaporin-2 excretion in response to furosemide in patients with chronic heart failure.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin II; Aquaporin 2; Arginine Vasopressin; Atrial Natriuretic Factor; Blood Pressure; Chronic Disease; Cross-Over Studies; Female; Furosemide; Glomerular Filtration Rate; Heart Failure; Humans; Male; Middle Aged; Natriuresis; Natriuretic Peptide, Brain; Renin | 2006 |
Influence of angiotensin converting enzyme inhibition on relation of atrial natriuretic peptide concentration to atrial pressure in heart failure.
Topics: Aged; Arginine Vasopressin; Atrial Natriuretic Factor; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Myocardial Ischemia; Peptidyl-Dipeptidase A; Pulmonary Wedge Pressure; Ramipril; Renin | 1994 |
Efficacy of prolonged infusion of urodilatin [ANP-(95-126)] in patients with congestive heart failure.
Topics: Aged; Aldosterone; Arginine Vasopressin; Atrial Natriuretic Factor; Cyclic GMP; Diuresis; Diuretics; Double-Blind Method; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Norepinephrine; Peptide Fragments; Renin; Time Factors | 1995 |
Early reduction of neurohumoral factors plays a key role in mediating the efficacy of beta-blocker therapy for congestive heart failure.
Topics: Adrenergic beta-Antagonists; Arginine Vasopressin; Atrial Natriuretic Factor; Carteolol; Female; Heart Failure; Humans; Lymphocytes; Male; Middle Aged; Myocardial Contraction; Norepinephrine; Propanolamines; Receptors, Adrenergic, beta; Renin-Angiotensin System; Time Factors; Ventricular Function, Left | 1996 |
Neurohumoral prediction of benefit from carvedilol in ischemic left ventricular dysfunction. Australia-New Zealand Heart Failure Group.
Topics: Arginine Vasopressin; Atrial Natriuretic Factor; Carbazoles; Carvedilol; Double-Blind Method; Heart Failure; Humans; Multivariate Analysis; Myocardial Ischemia; Natriuretic Peptide, Brain; Neuropeptides; Norepinephrine; Predictive Value of Tests; Prognosis; Propanolamines; Survival Analysis; Vasodilator Agents; Ventricular Dysfunction, Left | 1999 |
Selective V2-receptor vasopressin antagonism decreases urinary aquaporin-2 excretion in patients with chronic heart failure.
Topics: Administration, Oral; Aged; Aquaporin 2; Aquaporin 6; Aquaporins; Arginine Vasopressin; Azepines; Benzamides; Biomarkers; Blotting, Western; Dose-Response Relationship, Drug; Double-Blind Method; Female; Heart Failure; Humans; Male; Middle Aged; Pyrroles; Reference Values; Sensitivity and Specificity | 1999 |
Acute hemodynamic effects of conivaptan, a dual V(1A) and V(2) vasopressin receptor antagonist, in patients with advanced heart failure.
Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Double-Blind Method; Electrolytes; Female; Heart Failure; Hemodynamics; Humans; Kidney; Kinetics; Male; Middle Aged; Osmolar Concentration; Pulmonary Wedge Pressure; Urine | 2001 |
Renal, haemodynamic and hormonal interactions between atrial natriuretic factor and arginine vasopressin in patients with congestive heart failure.
Topics: Aged; Aldosterone; Arginine Vasopressin; Atrial Natriuretic Factor; Blood Pressure; Female; Heart Failure; Humans; Male; Middle Aged; Renin; Single-Blind Method; Sodium | 1992 |
Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD).
Topics: Arginine Vasopressin; Atrial Natriuretic Factor; Female; Heart Failure; Humans; Male; Middle Aged; Norepinephrine; Renin; Stroke Volume; Sympathetic Nervous System; Ventricular Function, Left | 1990 |
MDL 17,043 therapy in severe congestive heart failure: characterization of the early and late hemodynamic, pharmacokinetic, hormonal and clinical response.
Topics: Arginine Vasopressin; Cardiotonic Agents; Clinical Trials as Topic; Enoximone; Female; Follow-Up Studies; Half-Life; Heart Failure; Hemodynamics; Humans; Imidazoles; Kinetics; Male; Middle Aged; Norepinephrine; Renin | 1985 |
Modulation of plasma and platelet vasopressin by cardiac function in patients with heart failure.
Topics: Aged; Arginine Vasopressin; Blood Platelets; Captopril; Diuresis; Female; Glomerular Filtration Rate; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Prazosin; Sodium; Water-Electrolyte Balance | 1986 |
134 other study(ies) available for arginine vasopressin and Cardiac Failure
| Article | Year |
|---|---|
Peak Lag Between Plasma Vasopressin and Urine Aquaporin-2 Following Cardiac Surgery.
Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Aquaporin 2; Arginine Vasopressin; Biomarkers; Body Fluids; Cardiac Surgical Procedures; Female; Heart Failure; Hemodynamics; Humans; Kidney; Male; Middle Aged; Postoperative Care; Prospective Studies; Tolvaptan; Vasopressins | 2021 |
Impact of urine cyclic AMP relative to plasma arginine vasopressin on response to tolvaptan in patients with chronic kidney disease and heart failure.
Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Cyclic AMP; Heart Failure; Humans; Male; Prospective Studies; Renal Insufficiency, Chronic; Tolvaptan | 2023 |
Glucocorticoids Reverse Diluted Hyponatremia Through Inhibiting Arginine Vasopressin Pathway in Heart Failure Rats.
Topics: Animals; Aquaporin 2; Aquaporin 3; Arginine Vasopressin; Biomarkers; Dexamethasone; Disease Models, Animal; Diuretics; Down-Regulation; Epithelial Sodium Channels; Glucocorticoids; Heart Failure; Hyponatremia; Immediate-Early Proteins; Kidney Tubules, Collecting; Male; Protein Serine-Threonine Kinases; Rats, Wistar; Receptors, Vasopressin; Signal Transduction; Sodium; Sodium-Potassium-Chloride Symporters; Water-Electrolyte Balance | 2020 |
A heart-brain-kidney network controls adaptation to cardiac stress through tissue macrophage activation.
Topics: Adaptation, Physiological; Adrenergic beta-Antagonists; Amphiregulin; Animals; Aorta; Arginine Vasopressin; Blotting, Western; Bone Marrow Transplantation; Brain; Calgranulin A; Calgranulin B; Echocardiography; Endothelial Cells; Flow Cytometry; Gene Knockdown Techniques; Glomerular Filtration Rate; Granulocyte-Macrophage Colony-Stimulating Factor; Heart; Heart Failure; Immunohistochemistry; Kidney; Kidney Tubules, Collecting; Kruppel-Like Transcription Factors; Macrophages; Mice; Mice, Knockout; Myocardium; Norepinephrine; Real-Time Polymerase Chain Reaction; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Renal Artery; Stress, Physiological; Sympathectomy; Sympathetic Nervous System; Tumor Necrosis Factor-alpha | 2017 |
Combined Evaluation of the Plasma Arginine Vasopressin and Noradrenaline Levels May be a Useful Predictor of the Prognosis of Patients with Acute Decompensated Heart Failure.
Topics: Aged; Arginine Vasopressin; Biomarkers; Cardiovascular Diseases; Female; Heart Failure; Hospitalization; Humans; Japan; Male; Middle Aged; Natriuretic Peptide, Brain; Norepinephrine; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Risk Assessment | 2018 |
Association of arginine vasopressin with low atrial natriuretic peptide levels, left ventricular remodelling, and outcomes in adults with and without heart failure.
Topics: Aged; Arginine Vasopressin; Atrial Natriuretic Factor; Biomarkers; Disease Progression; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Heart Failure; Heart Ventricles; Humans; Hypertrophy, Left Ventricular; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Prognosis; Prospective Studies; Severity of Illness Index; Ventricular Remodeling | 2018 |
Sex differences in the central and peripheral manifestations of ischemia-induced heart failure in rats.
Topics: Animals; Arginine Vasopressin; Cyclooxygenase 2; Cytokines; Female; Heart Failure; Hemodynamics; Hypothalamus; Male; Myocardial Ischemia; Norepinephrine; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Sex Factors; Ventricular Function | 2019 |
Relationship between non-osmotic arginine vasopressin secretion and hemoglobin A1c levels in adult patients with congenital heart disease.
Topics: Adult; Arginine Vasopressin; Biomarkers; Diabetes Mellitus, Type 2; Disease Progression; Female; Glycated Hemoglobin; Heart Defects, Congenital; Heart Failure; Humans; Logistic Models; Male; Middle Aged; Natriuretic Peptide, Brain; Young Adult | 2019 |
Concurrent Use of Calcium Chloride and Arginine Vasopressin Infusions in Pediatric Patients with Acute Cardiocirculatory Failure.
Topics: Arginine Vasopressin; Blood Pressure; Calcium Chloride; Cardiac Output; Child, Preschool; Drug Therapy, Combination; Female; Heart Defects, Congenital; Heart Failure; Heart Rate; Humans; Infant; Infant, Newborn; Male; Retrospective Studies; Vasoconstrictor Agents | 2019 |
Obestatin ameliorates water retention in chronic heart failure by downregulating renal aquaporin 2 through GPR39, V2R and PPARG signaling.
Topics: Animals; Aquaporin 2; Arginine Vasopressin; Body Water; Cell Line; Edema; Ghrelin; Heart Failure; Kidney; Kidney Tubules, Collecting; Male; Mice; PPAR gamma; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; Receptors, Vasopressin; Signal Transduction; Water-Electrolyte Balance; Water-Electrolyte Imbalance | 2019 |
Tolvaptan for the treatment of hyponatremia and hypervolemia in patients with congestive heart failure.
Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Blood Volume; Dose-Response Relationship, Drug; Heart Failure; Homeostasis; Humans; Hyponatremia; Kidney; Sodium; Tolvaptan; Treatment Outcome | 2013 |
Validation of a commercially available enzyme immunoassay for measurement of plasma antidiuretic hormone concentration in healthy dogs and assessment of plasma antidiuretic hormone concentration in dogs with congestive heart failure.
Topics: Animals; Arginine Vasopressin; Dog Diseases; Dogs; Female; Heart Failure; Immunoenzyme Techniques; Male; Reproducibility of Results; Statistics, Nonparametric | 2013 |
Congestive heart failure in rats is associated with increased collecting duct vasopressin sensitivity and vasopressin type 2 receptor reexternalization.
Topics: Animals; Aquaporin 2; Arginine Vasopressin; Cyclic AMP; Disease Models, Animal; Female; Heart Failure; Kidney Cortex; Kidney Tubules, Collecting; Rats; Rats, Wistar; Receptors, Vasopressin | 2013 |
Revisiting vasopressin and heart failure.
Topics: Arginine Vasopressin; Heart Failure; Humans; Receptors, Vasopressin; Severity of Illness Index; Vasopressins | 2013 |
Vasopressin antagonists for patients with acute heart failure: interpreting new clinical and translational data.
Topics: Acute Disease; Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Clinical Trials as Topic; Drug Design; Heart Failure; Humans; Hyponatremia; Prognosis; Sodium; Translational Research, Biomedical | 2014 |
Sclederma of Poria cocos exerts its diuretic effect via suppression of renal aquaporin-2 expression in rats with chronic heart failure.
Topics: Administration, Oral; Animals; Aquaporin 2; Arginine Vasopressin; Chronic Disease; Disease Models, Animal; Diuretics; Dose-Response Relationship, Drug; Furosemide; Gene Expression Regulation; Heart Failure; Male; Myocardial Infarction; Plant Extracts; Poria; Rats; Rats, Sprague-Dawley; Receptors, Vasopressin; Time Factors | 2014 |
Awareness of the vasopressin system in heart failure.
Topics: Antidiuretic Hormone Receptor Antagonists; Aquaporin 2; Arginine Vasopressin; Benzazepines; Female; Heart Failure; Humans; Male; Tolvaptan | 2014 |
β-adrenergic receptor-mediated cardiac contractility is inhibited via vasopressin type 1A-receptor-dependent signaling.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Calcium Signaling; Cardiomyopathy, Hypertrophic; Cats; Cell Line, Tumor; Colforsin; Cyclic AMP; G-Protein-Coupled Receptor Kinases; Genes, Reporter; GTP-Binding Protein alpha Subunits, Gq-G11; Heart Failure; HEK293 Cells; Humans; Indoles; Isoproterenol; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mutagenesis, Site-Directed; Myocardial Contraction; Pyrrolidines; Receptors, Adrenergic, beta; Receptors, Vasopressin; Recombinant Fusion Proteins; Rolipram; Second Messenger Systems | 2014 |
Clarification of enrolled subjects in tolvaptan HF trials.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Drug Design; Heart Failure; Humans | 2014 |
Response to "clarification of enrolled subjects in tolvaptan HF trials".
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Drug Design; Heart Failure; Humans | 2014 |
Prolonged observation time reveals temporal fluctuations in the sublingual microcirculation in pigs given arginine vasopressin.
Topics: Animals; Arginine Vasopressin; Critical Care; Heart Failure; Microcirculation; Microscopy, Video; Mouth Floor; Myocardial Ischemia; Random Allocation; Swine; Time Factors | 2015 |
The secretion patterns and roles of cardiac and circulating arginine vasopressin during the development of heart failure.
Topics: Aldosterone; Animals; Arginine Vasopressin; Disease Models, Animal; Heart Failure; Male; Myocardium; Rats; Rats, Wistar; Ventricular Remodeling | 2015 |
Mid-Term Administration of Tolvaptan Improves Renal Function Accompanied by Dose-Reduction in Furosemide in Aquaporin-Defined Responders.
Topics: Antidiuretic Hormone Receptor Antagonists; Aquaporins; Arginine Vasopressin; Benzazepines; Diuretics; Furosemide; Heart Failure; Humans; Kidney Function Tests; Medication Therapy Management; Patient Selection; Tolvaptan | 2015 |
Response Prediction and Influence of Tolvaptan in Chronic Heart Failure Patients Considering the Interaction of the Renin-Angiotensin-Aldosterone System and Arginine Vasopressin.
Topics: Adult; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Body Mass Index; Female; Heart Failure; Humans; Male; Middle Aged; Prospective Studies; Renin-Angiotensin System; Tolvaptan; Treatment Outcome | 2016 |
Tolvaptan Improves the Long-Term Prognosis in Patients With Congestive Heart Failure With Preserved Ejection Fraction as Well as in Those With Reduced Ejection Fraction.
Topics: Adult; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Aquaporin 2; Arginine Vasopressin; Benzazepines; Female; Heart Failure; Hospitalization; Humans; Male; Middle Aged; Prognosis; Retrospective Studies; Stroke Volume; Tolvaptan | 2016 |
Tolvaptan Reduces Long-Term Total Medical Expenses and Length of Stay in Aquaporin-Defined Responders.
Topics: Adult; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Aquaporin 2; Arginine Vasopressin; Benzazepines; Female; Health Care Costs; Heart Failure; Humans; Length of Stay; Male; Middle Aged; Prognosis; Retrospective Studies; Stroke Volume; Tolvaptan | 2016 |
Elevation of arginine vasopressin levels following loop diuretic therapy as a prognostic indicator in heart failure.
Topics: Aged; Arginine Vasopressin; Biomarkers; Creatinine; Diuretics; Female; Heart Failure; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Osmolar Concentration; Prognosis; Proportional Hazards Models; Prospective Studies; Stroke Volume; Ventricular Function, Left | 2016 |
Central endothelin: effects on vasopressin and the arterial baroreflex in doxorubicin heart failure rats.
Topics: Animals; Arginine Vasopressin; Baroreflex; Doxorubicin; Endothelin A Receptor Antagonists; Endothelin-1; Female; Heart Failure; Kidney; Peptides, Cyclic; Rats; Rats, Sprague-Dawley; Sympathetic Nervous System | 2008 |
Molecular mechanisms of clinical concentrating and diluting disorders.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Aquaporin 2; Arginine Vasopressin; Blood Volume; Female; Heart Failure; Homeostasis; Humans; Hyponatremia; Liver Cirrhosis; Models, Biological; Polyuria; Pregnancy; Pregnancy Complications; Pressoreceptors; Sodium-Potassium-Chloride Symporters; Urine; Vasopressins; Water-Electrolyte Balance | 2008 |
Pathophysiological role of aquaporin-2 in impaired water excretion.
Topics: Animals; Aquaporin 2; Arginine Vasopressin; Bucladesine; Deamino Arginine Vasopressin; Disease Models, Animal; Diuresis; Gene Expression Regulation; Genes, Reporter; Heart Failure; Inappropriate ADH Syndrome; Kidney; Luciferases; Promoter Regions, Genetic; Rats; RNA, Messenger; Water-Electrolyte Imbalance | 2008 |
Hyponatremia in heart failure: concluding remarks.
Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Heart Failure; Humans; Hyponatremia; Receptors, Vasopressin; Sodium | 2009 |
Low-dose vasopressin infusion results in increased mortality and cardiac dysfunction following ischemia-reperfusion injury in mice.
Topics: Animals; Arginine Vasopressin; Cardiotonic Agents; Dobutamine; Heart Failure; Infusions, Intravenous; Male; Mice; Mice, Inbred C57BL; Myocardial Reperfusion Injury; Shock; Stroke Volume; Survival Analysis; Vasoconstrictor Agents; Ventricular Dysfunction, Left | 2009 |
Improving risk stratification in heart failure: a role for new biomarkers?
Topics: Adrenomedullin; Arginine Vasopressin; Atrial Natriuretic Factor; Biomarkers; Endothelin-1; Heart Failure; Humans; Natriuretic Peptide, Brain; Prognosis; Risk Adjustment; Vasodilator Agents | 2010 |
[Pathophysiology of heart failure for clinicians].
Topics: Algorithms; Arginine Vasopressin; Blood Pressure; Cardiac Output, Low; Cardiomegaly; Endothelins; Heart; Heart Diseases; Heart Failure; Heart Failure, Diastolic; Heart Failure, Systolic; Humans; Pressoreceptors; Prognosis; Renin-Angiotensin System; Sympathetic Nervous System; Vasoconstrictor Agents; Ventricular Remodeling | 2010 |
Differentiation of arginine vasopressin antagonistic effects by selective V2 versus dual V2/V1a receptor blockade in a preclinical heart failure model.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Blood Pressure; Cardiac Output; Cardiac Pacing, Artificial; Dogs; Heart Failure; Hemodynamics; Pacemaker, Artificial; Tolvaptan; Urodynamics; Vascular Resistance | 2011 |
Effect of exercise training on renal function and renal aquaporin-2 expression in rats with chronic heart failure.
Topics: Animals; Aquaporin 2; Arginine Vasopressin; Blood Urea Nitrogen; Collagen; Creatinine; Heart Failure; Heart Ventricles; Kidney; Male; Physical Conditioning, Animal; Rats; Rats, Sprague-Dawley; Tubulin | 2011 |
Serum and urine responses to the aquaretic agent tolvaptan in hospitalized hyponatremic patients.
Topics: Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Blood Pressure; Diuretics; Heart Failure; Humans; Hyponatremia; Inappropriate ADH Syndrome; Osmolar Concentration; Sodium; Tolvaptan | 2012 |
Effects of renal denervation on the NKCC2 cotransporter in the thick ascending limb of the loop of Henle in rats with congestive heart failure.
Topics: Animals; Arginine Vasopressin; Cyclic AMP; Disease Models, Animal; Heart Failure; Loop of Henle; Male; Phosphodiesterase Inhibitors; Rats; Rats, Wistar; Sodium-Hydrogen Exchanger 3; Sodium-Hydrogen Exchangers; Sodium-Potassium-Chloride Symporters; Solute Carrier Family 12, Member 1; Sympathectomy; Sympathetic Nervous System; Time Factors | 2012 |
Effects of tolvaptan on systemic and renal hemodynamic function in dogs with congestive heart failure.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Atrial Natriuretic Factor; Benzazepines; Blood Pressure; Body Weight; Chlorides; Disease Models, Animal; Diuretics; Dogs; Furosemide; Heart Failure; Kidney; Male; Potassium; Renin; Sodium; Tolvaptan | 2011 |
Chronic administration of oral vasopressin type 2 receptor antagonist tolvaptan exerts both myocardial and renal protective effects in rats with hypertensive heart failure.
Topics: Administration, Oral; Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Biomarkers; Blood Pressure; Disease Models, Animal; Disease Progression; Drug Administration Schedule; Heart Failure; Hormone Antagonists; Hypertension; Kidney; Kidney Diseases; Male; Myocardium; Natriuretic Peptides; Rats; Rats, Inbred Dahl; Receptors, Vasopressin; RNA, Messenger; Sodium Chloride, Dietary; Time Factors; Tolvaptan; Ultrasonography; Urination; Ventricular Dysfunction, Left; Ventricular Function, Left | 2012 |
Hyponatremia and outcomes in patients with heart failure.
Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Disease Progression; Global Health; Heart Failure; Humans; Hyponatremia; Incidence; Prognosis; Sodium; Survival Rate; Tolvaptan | 2012 |
Urinary aquaporin-2 in healthy humans and patients with liver cirrhosis and chronic heart failure during baseline conditions and after acute water load.
Topics: Adult; Aldosterone; Angiotensin II; Aquaporin 2; Aquaporin 6; Aquaporins; Arginine Vasopressin; Atrial Natriuretic Factor; Chronic Disease; Drinking; Female; Heart Failure; Humans; Liver Cirrhosis; Male; Middle Aged; Natriuretic Peptide, Brain; Osmolar Concentration; Renin; Urine; Water-Electrolyte Balance | 2003 |
The role of arginine vasopressin and its receptors in the normal and failing rat heart.
Topics: Animals; Arginine Vasopressin; Calcium; Heart; Heart Failure; Kinetics; Male; Myocardium; Rats; Rats, Sprague-Dawley; Receptors, Vasopressin | 2003 |
The inhibition by choline theophyllinate of water retention induced by pitressin.
Topics: Arginine Vasopressin; Choline; Heart Failure; Theophylline; Vasopressins | 1954 |
ALDOSTERONE, antidiuretic hormone and congestive heart failure.
Topics: Aldosterone; Arginine Vasopressin; Heart Failure; Humans; Vasopressins | 1958 |
[On a renal factor in the pathogenesis of edema of the late stages of cardiac insufficiency and liver cirrhosis].
Topics: Arginine Vasopressin; Edema; Heart Failure; Humans; Liver Cirrhosis; Vasopressins | 1961 |
[The antidiuretic hormone (ADH) and heart insufficiency. 1. Comparative evaluation of methods of extracting ADH from human urine and isolation of antidiuretic hormones by paper electrophoresis].
Topics: Arginine Vasopressin; Electrophoresis, Paper; Heart Failure; Humans; Vasopressins | 1963 |
[ON THE QUESTION OF ANTIDIURETIC HORMONE CONCENTRATION IN HUMAN BLOOD PLASMA].
Topics: Arginine Vasopressin; Blood Chemical Analysis; Edema; Heart Failure; Humans; Obesity; Vasopressins | 1964 |
Effect of exercise on natriuretic peptides in plasma and urine in chronic heart failure.
Topics: Angiotensin II; Aquaporin 2; Aquaporins; Arginine Vasopressin; Atrial Natriuretic Factor; Case-Control Studies; Exercise; Exercise Test; Exercise Tolerance; Female; Heart Failure; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Natriuretic Peptide, C-Type; Osmolar Concentration; Radioimmunoassay | 2004 |
Basal and exercise-induced neuroendocrine activation in patients with heart failure and in normal subjects.
Topics: Aged; Aged, 80 and over; Arginine Vasopressin; Case-Control Studies; Endothelin-1; Exercise; Exercise Tolerance; Female; Heart Failure; Humans; Male; Natriuretic Peptides; Neurosecretory Systems; Norepinephrine; Renin | 2004 |
Vasopressin receptor antagonists: will the "vaptans" fulfill their promise?
Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Cardiovascular Agents; Heart Failure; Humans; Tolvaptan | 2004 |
Arginine vasopressin levels are elevated and correlate with functional status in infants and children with congestive heart failure.
Topics: Arginine Vasopressin; Cardiomyopathy, Dilated; Case-Control Studies; Child; Child, Preschool; Female; Heart Failure; Humans; Infant; Male; Pulmonary Circulation; Severity of Illness Index; Stroke Volume; Ventricular Dysfunction, Left | 2004 |
Urinary excretion of aquaporin-2 water channel exaggerated dependent upon vasopressin in congestive heart failure.
Topics: Adult; Aged; Aged, 80 and over; Aquaporin 2; Aquaporins; Arginine Vasopressin; Female; Heart Failure; Humans; Male; Middle Aged; Osmolar Concentration; Pressoreceptors; Sodium | 2004 |
Possible vascular role of increased plasma arginine vasopressin in congestive heart failure.
Topics: Adult; Aged; Aged, 80 and over; Arginine Vasopressin; Atrial Natriuretic Factor; Case-Control Studies; Female; Heart Failure; Humans; Linear Models; Male; Middle Aged; Natriuretic Peptide, Brain; Norepinephrine | 2006 |
The clinical effects of vasopressin receptor antagonists in heart failure.
Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Biomarkers; Disease Progression; Heart Failure; Hemodynamics; Humans; Hyponatremia; Prognosis; Receptors, Vasopressin | 2006 |
[Vasopressin as a rescue vasopressor agent. Treatment of selected cardiogenic shock states].
Topics: Aged; Aged, 80 and over; Arginine Vasopressin; Blood Pressure; Critical Illness; Diabetes Mellitus, Type 2; Female; Heart Failure; Heart Rate; Humans; Hyperlipidemias; Hypertension; Male; Middle Aged; Myocardial Infarction; Postoperative Complications; Pulmonary Wedge Pressure; Sepsis; Shock, Cardiogenic; Treatment Outcome; Vasoconstrictor Agents | 2007 |
Effects of nonpeptide vasopressin V2 antagonist tolvaptan in rats with heart failure.
Topics: Aldosterone; Animals; Antidiuretic Hormone Receptor Antagonists; Aquaporin 2; Arginine Vasopressin; Benzazepines; Cardiac Myosins; Diuretics; Heart; Heart Failure; Hemodynamics; Kidney; Male; Organ Size; Osmolar Concentration; Rats; Rats, Inbred Lew; Sodium; Tolvaptan | 2007 |
Urocortin 2 combined with angiotensin-converting enzyme inhibition in experimental heart failure.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine Vasopressin; Atrial Natriuretic Factor; Blood Pressure; Captopril; Cardiac Output; Cardiac Pacing, Artificial; Drug Therapy, Combination; Endothelin-1; Epinephrine; Female; Heart Failure; Models, Animal; Renin; Renin-Angiotensin System; Sheep; Urocortins; Vascular Resistance | 2008 |
Effects of V2-receptor antagonist tolvaptan and the loop diuretic furosemide in rats with heart failure.
Topics: Aldosterone; Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Blood Pressure; Body Weight; Creatinine; Diuretics; Echocardiography; Furosemide; Heart Failure; Heart Rate; Male; Organ Size; Osmolar Concentration; Potassium; Rats; Rats, Inbred Lew; Renin; Sodium; Tolvaptan; Ventricular Remodeling | 2008 |
Copeptin: clinical use of a new biomarker.
Topics: Arginine Vasopressin; Biomarkers; Diabetes Insipidus; Glycopeptides; Heart Failure; Humans; Models, Biological; Sepsis; Shock; Water-Electrolyte Imbalance | 2008 |
Evidence against concept of hyponatraemia and "sick cells".
Topics: Arginine Vasopressin; Heart Failure; Humans; Hyponatremia; Kidney; Liver Cirrhosis; Osmolar Concentration | 1982 |
Role of the renin-angiotensin system in the development of congestive heart failure in the dog as assessed by chronic converting-enzyme blockade.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine Vasopressin; Captopril; Cardiac Output; Cardiac Pacing, Artificial; Heart Failure; Norepinephrine; Proline; Pulmonary Wedge Pressure; Renin; Renin-Angiotensin System; Vascular Resistance | 1984 |
Increased plasma arginine vasopressin levels in patients with congestive heart failure.
Topics: Arginine Vasopressin; Captopril; Cardiac Output; Female; Heart Failure; Humans; Male; Middle Aged; Nitroprusside; Norepinephrine; Radioimmunoassay; Renin; Renin-Angiotensin System; Vascular Resistance; Vasomotor System; Water-Electrolyte Balance | 1983 |
Impaired response of plasma vasopressin to orthostatic stress in patients with congestive heart failure.
Topics: Adult; Aged; Arginine Vasopressin; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Norepinephrine; Posture; Renin; Stress, Physiological | 1983 |
The acute response of plasma norepinephrine, renin activity, and arginine vasopressin to short-term nitroprusside and nitroprusside withdrawal in patients with congestive heart failure.
Topics: Arginine Vasopressin; Ferricyanides; Heart Failure; Humans; Nitroprusside; Norepinephrine; Renin; Substance Withdrawal Syndrome | 1983 |
Radioimmunoassay of plasma arginine vasopressin in hyponatremic patients with congestive heart failure.
Topics: Arginine Vasopressin; Heart Failure; Humans; Hyponatremia; Radioimmunoassay; Vasopressins | 1981 |
Plasma arginine vasopressin in hyponatremic patients with heart failure.
Topics: Animals; Arginine Vasopressin; Dogs; Heart Failure; Humans; Hyponatremia | 1981 |
Effects of oral AVP receptor antagonists OPC-21268 and OPC-31260 on congestive heart failure in conscious dogs.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Body Weight; Capillary Resistance; Cardiac Output; Cardiac Pacing, Artificial; Diuresis; Dogs; Heart Failure; Hemodynamics; Kidney; Male; Natriuresis; Osmolar Concentration; Piperidines; Potassium; Quinolones; Renin; Sodium | 1994 |
Short-term effects of eating on vasoactive hormones and haemodynamics in patients with heart failure.
Topics: Aged; Arginine Vasopressin; Atrial Natriuretic Factor; Eating; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Peptidyl-Dipeptidase A; Pulmonary Wedge Pressure | 1994 |
Effects of beta-blockade on neurohumoral responses and neurochemical markers in pacing-induced heart failure.
Topics: Animals; Arginine Vasopressin; Atrial Natriuretic Factor; Bicarbonates; Biomarkers; Body Weight; Cardiac Pacing, Artificial; Cardiomegaly; Dogs; Electric Stimulation; Electrolytes; Heart; Heart Failure; Muscle Denervation; Neuropeptide Y; Neuropeptides; Norepinephrine; Oxygen; Partial Pressure; Propranolol; Reference Values; Respiration; Vagus Nerve; Ventricular Function, Left | 1994 |
Enhanced coronary vasoconstriction in the Syrian myopathic hamster supports the microvascular spasm hypothesis.
Topics: Aging; Animals; Arginine Vasopressin; Coronary Vessels; Cricetinae; Heart Failure; Male; Mesocricetus; Microcirculation; Perfusion; Vascular Resistance; Vasoconstriction | 1994 |
[The changes in plasma arginine-vasopressin in patients with essential hypertension and the correlation with patient's condition].
Topics: Adult; Aged; Arginine Vasopressin; Female; Heart Failure; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Nitrendipine | 1993 |
The effect of OPC-21268, an oral, nonpeptide arginine vasopressin V1 receptor antagonist, on a patient with congestive heart failure.
Topics: Adult; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Blood Pressure; Diabetes Mellitus, Type 2; Female; Heart Failure; Heart Rate; Humans; Kidney Failure, Chronic; Piperidines; Quinolones | 1993 |
Control of arginine vasopressin and congestive heart failure.
Topics: Arginine Vasopressin; Heart Failure; Humans; Hydralazine | 1993 |
Role of AVP in the regulation of vascular tonus and blood pressure in patients with chronic renal failure.
Topics: Adult; Aged; Arginine Vasopressin; Blood Pressure; Heart Failure; Humans; Hypertension; Hypotension; Kidney Failure, Chronic; Middle Aged; Muscle Tonus; Muscle, Smooth, Vascular; Renal Dialysis | 1993 |
Stress triggers different pathophysiological mechanisms in younger and older cardiomyopathic hamsters.
Topics: Age Factors; Aging; Animals; Arginine Vasopressin; Cardiomyopathies; Coronary Vasospasm; Coronary Vessels; Cricetinae; Heart; Heart Failure; Stress, Psychological; Vascular Resistance | 1995 |
Adrenomedullin gene expression in the rat heart is stimulated by acute pressure overload: blunted effect in experimental hypertension.
Topics: Adrenomedullin; Animals; Arginine Vasopressin; Atrial Natriuretic Factor; Blood Pressure; Heart; Heart Failure; Heart Ventricles; Humans; Hypertension; Male; Myocardium; Natriuretic Peptide, Brain; Peptide Biosynthesis; Peptides; Rats; Rats, Inbred Strains; Rats, Sprague-Dawley; RNA, Messenger; Time Factors; Transcription, Genetic | 1997 |
Therapeutic efficacy of vasopressin receptor antagonists.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Diuresis; Edema; Heart Failure; Humans; Hyponatremia; Inappropriate ADH Syndrome; Liver Cirrhosis; Rats | 1998 |
Long-term effects of nonpeptide vasopressin V2 antagonist OPC-31260 in heart failure in the rat.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Blood Pressure; Body Weight; Diuresis; Female; Heart; Heart Failure; Hemodynamics; Lung; Myocardial Infarction; Organ Size; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Survival Analysis; Systole | 1998 |
Differential upregulation of rat Na-K-Cl cotransporter, rBSC1, mRNA in the thick ascending limb of Henle in different pathological conditions.
Topics: Animals; Arginine Vasopressin; Carrier Proteins; Dehydration; Gene Expression Regulation; Heart Failure; In Situ Hybridization; Loop of Henle; Male; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sodium-Potassium-Chloride Symporters; Up-Regulation | 1998 |
Mechanisms of the therapeutic effect of astragalus membranaceus on sodium and water retention in experimental heart failure.
Topics: Animals; Arginine Vasopressin; Arteriovenous Shunt, Surgical; Astragalus propinquus; Atrial Natriuretic Factor; Cardiotonic Agents; Diuretics; Drugs, Chinese Herbal; Heart Failure; Male; Random Allocation; Rats; Rats, Sprague-Dawley; RNA, Messenger | 1998 |
AlphaANP, AVP, and pituitary-thyroid axis in patients with congestive heart failure and acute respiratory failure.
Topics: Acute Disease; Aged; Aged, 80 and over; Arginine Vasopressin; Atrial Natriuretic Factor; Female; Follow-Up Studies; Heart Failure; Hospitalization; Humans; Male; Middle Aged; Pituitary Gland; Prognosis; Respiratory Insufficiency; Thyroid Function Tests; Thyroid Gland | 1999 |
Renal endothelin in heart failure and its relation to sodium excretion.
Topics: Aged; Arginine Vasopressin; Atrial Natriuretic Factor; Biomarkers; Circadian Rhythm; Disease Progression; Endothelin-1; Female; Heart Failure; Hemodynamics; Humans; Kidney; Male; Middle Aged; Natriuretic Peptide, Brain; Prognosis; Radioimmunoassay; Renin; Severity of Illness Index; Sodium; Survival Rate | 2000 |
Gene transfer of heterologous G protein-coupled receptors to cardiomyocytes: differential effects on contractility.
Topics: Adenoviridae; Adenylate Cyclase Toxin; Animals; Arginine Vasopressin; Culture Media, Conditioned; Cyclic AMP; Deamino Arginine Vasopressin; Dose-Response Relationship, Drug; Gene Transfer Techniques; Genetic Vectors; Green Fluorescent Proteins; GTP-Binding Proteins; Heart Failure; Luminescent Proteins; Myocardial Contraction; Myocardium; Parathyroid Hormone; Parathyroid Hormone-Related Protein; Peptide Fragments; Proteins; Rabbits; Radioligand Assay; Receptors, Cell Surface; Receptors, Parathyroid Hormone; Receptors, Vasopressin; Recombinant Fusion Proteins; Signal Transduction; Transgenes; Type C Phospholipases; Virulence Factors, Bordetella | 2001 |
Temporal changes in natriuretic and antinatriuretic systems after closure of a large arteriovenous fistula.
Topics: Animals; Arginine Vasopressin; Arteriovenous Shunt, Surgical; Atrial Natriuretic Factor; Blood Pressure; Heart Failure; Hormones; Kidney; Male; Natriuresis; Nitric Oxide Synthase; Rats; Rats, Wistar; Renin; Sodium; Urine | 2001 |
Evaluation of impaired left ventricular ejection fraction and increased dimensions by multiple neurohumoral plasma concentrations.
Topics: Aged; Aldosterone; Arginine Vasopressin; Atrial Natriuretic Factor; Biomarkers; Blood Pressure; Endothelin-1; Epinephrine; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Neurotransmitter Agents; Norepinephrine; Regression Analysis; Renin; Stroke Volume; Ventricular Dysfunction, Left | 2001 |
Vasopressin antagonists in CHF: ready for clinical trials?
Topics: Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Benzazepines; Heart Failure; Humans | 2002 |
Neurohormonal antagonism in heart failure; beneficial effects of vasopressin V(1a) and V(2) receptor blockade and ACE inhibition.
Topics: Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Atrial Natriuretic Factor; Benzazepines; Blood Pressure; Captopril; Female; Heart Failure; Myocardium; Osmolar Concentration; Rats; Rats, Sprague-Dawley; Renin | 2002 |
Aortic input impedance in mild to moderate chronic congestive heart failure: lack of interrelation with neurohormonal activation.
Topics: Arginine Vasopressin; Atrial Natriuretic Factor; Blood Flow Velocity; Blood Pressure; Cardiac Output; Cardiac Volume; Female; Heart Failure; Hemodynamics; Homeostasis; Humans; Male; Middle Aged; Myocardial Contraction; Neurotransmitter Agents; Norepinephrine; Renin; Stroke Volume; Vascular Resistance; Ventricular Function, Left | 1992 |
[Effects of treatment of arrhythmias requiring therapy in dilated cardiomyopathy with amiodarone on alpha human atrial natriuretic peptide].
Topics: Aged; Aldosterone; Amiodarone; Arginine Vasopressin; Arrhythmias, Cardiac; Atrial Natriuretic Factor; Captopril; Cardiomyopathy, Dilated; Drug Therapy, Combination; Electrocardiography, Ambulatory; Enalapril; Female; Heart Failure; Hemodynamics; Humans; Longitudinal Studies; Male; Middle Aged | 1992 |
Haemodynamic and neurohumoral response in heart failure produced by rapid ventricular pacing.
Topics: Animals; Arginine Vasopressin; Atrial Natriuretic Factor; Blood Pressure; Cardiac Output; Cardiac Pacing, Artificial; Disease Models, Animal; Dogs; Heart Failure; Hemodynamics; Norepinephrine; Radioimmunoassay; Renin | 1992 |
Baroreflex loading maneuvers do not suppress increased plasma arginine vasopressin in patients with congestive heart failure.
Topics: Adult; Aged; Analysis of Variance; Arginine Vasopressin; Atrial Natriuretic Factor; Chronic Disease; Female; Heart Failure; Hemodynamics; Humans; Male; Mannitol; Middle Aged; Posture; Pressoreceptors; Reflex; Time Factors | 1992 |
Haemodynamic and neurohumoral effects of cold pressor test in severe heart failure.
Topics: Aged; Arginine Vasopressin; Blood Pressure; Cold Temperature; Epinephrine; Female; Heart Failure; Hemodynamics; Humans; Male; Norepinephrine; Sympathetic Nervous System; Vascular Resistance | 1992 |
[Advanced heart failure: possible role of endothelin for renal failure; baroreceptor mechanism of vasopressin (AVP) stimulation in advanced heart failure and hyponatremia].
Topics: Acute Kidney Injury; Aged; Arginine Vasopressin; Creatinine; Endothelins; Female; Heart Failure; Humans; Hyponatremia; Male; Middle Aged; Posture; Pressoreceptors | 1991 |
Changes in AVP following aggressive diuretic therapy of severe congestive cardiac failure in elderly patients.
Topics: Aged; Aged, 80 and over; Arginine Vasopressin; Diuretics; Heart Failure; Humans; Prospective Studies | 1991 |
Effects of chronic administration of a vasopressin antagonist with combined antivasopressor and antiantidiuretic activities in rats with left ventricular dysfunction.
Topics: Animals; Arginine Vasopressin; Diuresis; Heart Failure; Kidney; Male; Rats; Rats, Inbred Strains; Receptors, Angiotensin; Receptors, Vasopressin | 1991 |
Vasopressin and angiotensin II contribute equally to the increased afterload in rabbits with heart failure.
Topics: Angiotensin II; Animals; Arginine Vasopressin; Blood Pressure; Captopril; Cardiac Output; Disease Models, Animal; Female; Heart Failure; Male; Rabbits; Vascular Resistance; Vasopressins | 1991 |
Gamma 2-MSH in congestive heart failure: relation to atrial natriuretic peptide, arginine vasopressin and catecholamines.
Topics: Aged; Aged, 80 and over; Arginine Vasopressin; Atrial Natriuretic Factor; Epinephrine; Female; Heart Failure; Humans; Male; Melanocyte-Stimulating Hormones; Middle Aged; Norepinephrine; Radioimmunoassay | 1990 |
Control of atrial natriuretic peptide secretion in patients with severe congestive heart failure.
Topics: Adult; Arginine Vasopressin; Atrial Natriuretic Factor; Blood Pressure; Blood Volume; Body Water; Female; Heart Failure; Humans; Infusions, Intravenous; Male; Mannitol; Middle Aged; Sodium; Vasoconstriction | 1990 |
Pressor systems in hypertension and congestive heart failure. Role of vasopressin.
Topics: Adult; Arginine Vasopressin; Blood Pressure; Heart Failure; Humans; Hypertension; Male; Middle Aged | 1990 |
Selective vasopressin inhibition in rats with heart failure decreases afterload and results in venodilatation.
Topics: Animals; Arginine Vasopressin; Blood Circulation; Heart Failure; Hemodynamics; Male; Myocardial Infarction; Rats; Rats, Inbred Strains; Vasodilation; Veins | 1990 |
Attenuation of pressor responses to arginine vasopressin in right-sided congestive heart failure.
Topics: Animals; Aorta; Arginine Vasopressin; Blood Pressure; Dogs; Dose-Response Relationship, Drug; Heart Failure; Hemodynamics; Methoxamine; Prazosin; Pressoreceptors; Propranolol; Reference Values; Reflex; Sympatholytics | 1990 |
Effects of a vasopressin antagonist with combined antipressor and antiantidiuretic activities in rats with left ventricular dysfunction.
Topics: Animals; Antihypertensive Agents; Arginine Vasopressin; Diuresis; Heart Failure; Male; Rats; Rats, Inbred Strains; Ultrasonography; Vascular Resistance; Vasopressins | 1990 |
Vasopressin in congestive heart failure.
Topics: Arginine Vasopressin; Blood Platelets; Blood Volume; Heart Failure; Humans; Renin; Vasopressins | 1986 |
Clinical studies with a vascular vasopressin antagonist.
Topics: Angiotensin II; Arginine Vasopressin; Heart Failure; Hemodynamics; Humans; Hypertension; Smoking; Steam Bath; Vasopressins | 1986 |
Natriuretic factors and lithium clearance in patients with the syndrome of inappropriate antidiuretic hormone (SIADH)
Topics: Aged; Arginine Vasopressin; Atrial Natriuretic Factor; Blood Proteins; Cardenolides; Digoxin; Dopamine; Female; Heart Failure; Humans; Hyponatremia; Inappropriate ADH Syndrome; Lithium; Liver Cirrhosis; Male; Middle Aged; Plasma Volume; Saponins | 1989 |
Peripheral hemodynamic and humoral effects of oral zofenopril calcium (SQ. 26,991) in patients with congestive heart failure.
Topics: Administration, Oral; Aged; Angiotensin I; Arginine Vasopressin; Atrial Natriuretic Factor; Blood Pressure; Captopril; Female; Forearm; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Renin; Vasodilation; Veins | 1989 |
Neuroendocrine response in acute heart failure and the influence of treatment.
Topics: Acute Disease; Aged; Aldosterone; Angiotensin II; Arginine Vasopressin; Atrial Natriuretic Factor; Catecholamines; Cyclic GMP; Diuretics; Female; Furosemide; Heart Failure; Humans; Male; Middle Aged; Neurotransmitter Agents | 1989 |
Renal and hormonal effects of phosphodiesterase III inhibition in congestive heart failure.
Topics: Aldosterone; Arginine Vasopressin; Forearm; Glomerular Filtration Rate; Heart Failure; Hormones; Humans; Kidney; Milrinone; Norepinephrine; Phosphodiesterase Inhibitors; Pyridones; Regional Blood Flow; Renal Circulation; Renin | 1989 |
Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure. Activation of the neurohumoral axis.
Topics: Adult; Aged; Arginine Vasopressin; Female; Furosemide; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Neurotransmitter Agents; Norepinephrine; Renin; Vasoconstriction | 1985 |
Neurohumoral vasoconstrictor systems in heart failure.
Topics: Angiotensin II; Animals; Arginine Vasopressin; Captopril; Cardiac Output; Dogs; Heart; Heart Failure; Neurotransmitter Agents; Norepinephrine; Osmolar Concentration; Prazosin; Rats; Rats, Inbred Strains; Renin-Angiotensin System; Vascular Resistance; Vasoconstriction | 1985 |
Spontaneous neurohormonal fluctuation in chronic congestive heart failure.
Topics: Adult; Aged; Aldosterone; Arginine Vasopressin; Chronic Disease; Circadian Rhythm; Electrolytes; Female; Heart Failure; Humans; Male; Neurotransmitter Agents; Osmolar Concentration; Renin | 1988 |
Hemodynamic, renal, and neurohumoral effects of a selective oral DA1 receptor agonist (fenoldopam) in patients with congestive heart failure.
Topics: Administration, Oral; Aldosterone; Arginine Vasopressin; Benzazepines; Fenoldopam; Heart Failure; Hemodynamics; Humans; Kidney; Middle Aged; Norepinephrine; Receptors, Dopamine; Regional Blood Flow; Renin; Vasodilator Agents | 1988 |
Comparative hemodynamic and hormonal response of enoximone and dobutamine in severe congestive heart failure.
Topics: Aged; Arginine Vasopressin; Cardiotonic Agents; Depression, Chemical; Dobutamine; Enoximone; Female; Heart Failure; Hemodynamics; Humans; Imidazoles; Male; Middle Aged; Norepinephrine; Renin; Stimulation, Chemical | 1986 |
Salt and water balance in congestive heart failure.
Topics: Arginine Vasopressin; Atrial Natriuretic Factor; Blood Volume; Edema; Extracellular Space; Glomerular Filtration Rate; Heart Failure; Humans; Renal Circulation; Renin-Angiotensin System; Sodium Chloride; Water-Electrolyte Balance | 1986 |
[Neuroendocrine changes in chronic cardiac insufficiency].
Topics: Arginine Vasopressin; Atrial Natriuretic Factor; Chronic Disease; Heart Failure; Hemodynamics; Humans; Kinins; Norepinephrine; Prostaglandins E; Renin-Angiotensin System; Sympathetic Nervous System; Vasoconstriction; Vasodilation | 1988 |
Plasma vasopressin as influenced by acute and chronic blockade of the renin-angiotensin system.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Arginine Vasopressin; Captopril; Female; Heart Failure; Humans; Male; Middle Aged; Renin-Angiotensin System | 1985 |
Role of vasopressin in experimental heart failure.
Topics: Animals; Aortic Valve Stenosis; Arginine Vasopressin; Blood Pressure; Captopril; Disease Models, Animal; Dogs; Heart Failure; Pulmonary Valve Stenosis; Rats; Renin-Angiotensin System; Teprotide; Water-Electrolyte Balance | 1988 |
Role of diuretics, hormonal derangements, and clinical setting of hyponatremia in medical patients.
Topics: Aldosterone; Arginine Vasopressin; Diuretics; Electrolytes; Epinephrine; Furosemide; Heart Failure; Hormones; Humans; Hyponatremia; Inappropriate ADH Syndrome; Kidney Failure, Chronic; Liver Cirrhosis; Renin; Water-Electrolyte Balance | 1988 |
Angiotensin II, aldosterone and arginine vasopressin in plasma in congestive heart failure.
Topics: Aged; Aldosterone; Angiotensin II; Arginine Vasopressin; Drinking; Female; Heart Failure; Humans; Kidney Concentrating Ability; Male; Middle Aged; Renin-Angiotensin System; Water-Electrolyte Balance | 1986 |
Plasma vasopressin response to osmotic and hemodynamic stimuli in heart failure.
Topics: Aged; Arginine Vasopressin; Blood Pressure; Cardiac Catheterization; Cardiac Output; Cardiotonic Agents; Contrast Media; Enoximone; Heart Failure; Hemodynamics; Humans; Imidazoles; Middle Aged; Osmolar Concentration; Osmotic Pressure; Water-Electrolyte Balance | 1985 |
Short-term hemodynamic effects of vasopressin V1-receptor inhibition in chronic right-sided congestive heart failure.
Topics: Animals; Arginine Vasopressin; Cardiac Output; Chronic Disease; Dogs; Epinephrine; Heart Failure; Heart Rate; Hemodynamics; Norepinephrine; Prazosin; Propranolol; Regional Blood Flow | 1988 |
Combined therapy with dobutamine and amrinone in severe heart failure. Improved hemodynamics and increased activation of the renin-angiotensin system with combined intravenous therapy.
Topics: Adult; Amrinone; Arginine Vasopressin; Dobutamine; Drug Therapy, Combination; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Norepinephrine; Renin; Renin-Angiotensin System | 1987 |
Variable arginine vasopressin levels in neonatal congestive heart failure.
Topics: Acute Disease; Arginine Vasopressin; Coronary Circulation; Heart Failure; Humans; Hypotension; Infant, Newborn; Pressoreceptors; Ventricular Outflow Obstruction | 1988 |
Contribution of vasopressin to vasoconstriction in patients with congestive heart failure: comparison with the renin-angiotensin system and the sympathetic nervous system.
Topics: Aged; Arginine Vasopressin; Captopril; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Norepinephrine; Phentolamine; Renin; Renin-Angiotensin System; Sympathetic Nervous System; Vascular Resistance; Vasoconstriction; Vasopressins | 1986 |
Vasopressin, renin and norepinephrine levels before and after captopril administration in patients with congestive heart failure due to idiopathic dilated cardiomyopathy.
Topics: Arginine Vasopressin; Blood; Captopril; Heart Failure; Hemodynamics; Humans; Norepinephrine; Osmolar Concentration; Renin | 1986 |
Effectiveness of vasopressin regulation of coronary blood flow in congestive heart failure secondary to idiopathic dilated or ischemic cardiomyopathy.
Topics: Adult; Aged; Arginine Vasopressin; Cardiomyopathy, Dilated; Coronary Circulation; Double-Blind Method; Female; Heart Failure; Humans; Male; Middle Aged; Vascular Resistance | 1987 |
Arginine vasopressin and the renal response to water loading in congestive heart failure.
Topics: Adult; Aged; Arginine Vasopressin; Blood; Female; Heart Failure; Humans; Kidney; Male; Middle Aged; Osmolar Concentration; Urine; Water; Water-Electrolyte Balance | 1986 |
Hemodynamic effects of infused arginine vasopressin in congestive heart failure.
Topics: Adult; Aged; Arginine Vasopressin; Cardiac Output; Heart Failure; Hemodynamics; Humans; Middle Aged; Stroke Volume; Vascular Resistance | 1986 |
Hormonal, global, and regional haemodynamic responses to a vascular antagonist of vasopressin in patients with congestive heart failure with and without hyponatraemia.
Topics: Adult; Aged; Arginine Vasopressin; Female; Heart Failure; Hemodynamics; Humans; Hyponatremia; Male; Middle Aged; Time Factors | 1986 |
[Hemodynamic effects of an inhibitor of the vascular effects of vasopressin in patients with congestive heart failure].
Topics: Adult; Arginine Vasopressin; Female; Heart Failure; Hemodynamics; Humans; Male; Osmolar Concentration; Vasopressins | 1985 |
Acute hemodynamic effect of a vascular antagonist of vasopressin in patients with congestive heart failure.
Topics: Adult; Aged; Arginine Vasopressin; Blood Pressure; Cardiac Output; Epinephrine; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Norepinephrine; Regional Blood Flow; Renin; Skin | 1985 |
Influence of heart failure and sodium content in the diet on the natriuretic response to furosemide in hamsters.
Topics: Animals; Arginine Vasopressin; Cardiomyopathy, Dilated; Cricetinae; Diet, Sodium-Restricted; Female; Furosemide; Heart Failure; Indomethacin; Male; Mesocricetus; Natriuresis; Renin; Time Factors | 1985 |
Response of plasma vasopressin to ethanol in congestive heart failure.
Topics: Arginine Vasopressin; Blood Pressure; Ethanol; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Osmolar Concentration | 1985 |